{
    "KO": {
        "tab_sim": "ğŸ“ˆ ì‹œë®¬ë ˆì´ì…˜",
        "tab_safe": "ğŸš‘ ì•ˆì „ ë° ì‘ê¸‰ ëŒ€ì²˜",
        "tab_cal": "ğŸ§ª í”¼ê²€ì‚¬ ë³´ì •",
        "tab_surg": "ğŸ—“ï¸ ì¥ê¸° ê³„íš",
        "tab_rep": "ğŸ“‚ ê°€ì ¸ì˜¤ê¸°/ë‚´ë³´ë‚´ê¸°",
        "tab_faq": "ğŸ“š ìì£¼ ë¬»ëŠ” ì§ˆë¬¸ê³¼ ì¶œì²˜",
        "sidebar_profile": "ğŸ§ 1. ì‹ ì²´ ì •ë³´",
        "sidebar_add": "ğŸ’Š 2. ì•½ë¬¼ ì¶”ê°€",
        "sidebar_risk": "ğŸ›¡ï¸ 3. í™˜ì ë¦¬ìŠ¤í¬ í‰ê°€",
        "sidebar_settings": "âš™ï¸ 4. ì„¤ì •",
        "sidebar_patient": "ğŸ¥ í™˜ì ì„ íƒ",
        "settings_lang_label": "ğŸŒ ì–¸ì–´",
        "force_offline_label": "ğŸ› ï¸ ì˜¤í”„ë¼ì¸ ëª¨ë“œ ê°•ì œ",
        "force_offline_help": "ë¡œì»¬/ì˜¤í”„ë¼ì¸ í™˜ê²½ì²˜ëŸ¼ ë™ì‘í•˜ë„ë¡ ê°•ì œë¡œ ì „í™˜í•©ë‹ˆë‹¤.",
        "default_user": "ì‚¬ìš©ì",
        "patient_name": "í™˜ì ì„±í•¨",
        "patient_id_label": "í™˜ì ë²ˆí˜¸",
        "weight_label": "ì²´ì¤‘ (kg)",
        "height_label": "ì‹ ì¥ (cm)",
        "calculated_bmi": "ğŸ’¡ ê³„ì‚°ëœ BMI: **{bmi:.1f}**",
        "age_label": "ë‚˜ì´",
        "body_fat_label": "ì²´ì§€ë°©ë¥  (%)",
        "profile_details_toggle": "ìƒì„¸ ì •ë³´ ì…ë ¥ (ê°„ìˆ˜ì¹˜/ì²´ì§€ë°©)",
        "ast_label": "AST (U/L)",
        "alt_label": "ALT (U/L)",
        "peak": "ìµœê³ ì¹˜",
        "trough": "ìµœì €ì¹˜",
        "avg": "í‰ê· ",
        "fluctuation": "ë³€ë™í­",
        "max_slope": "ìµœëŒ€ ë³€í™”ìœ¨",
        "rmse_label": "RMSE (ì˜¤ì°¨)",
        "splash_msg": "ì‹œìŠ¤í…œì„ ì´ˆê¸°í™”í•˜ê³  ìˆìŠµë‹ˆë‹¤. ì ì‹œë§Œ ê¸°ë‹¤ë ¤ ì£¼ì„¸ìš”.",
        "dashboard_title": "Dashboard",
        "landing_lang_label": "ğŸŒ Language",
        "landing_disclaimer_title": "âš ï¸ **ì‚¬ìš© ì „ ì£¼ì˜ì‚¬í•­**",
        "landing_disclaimer_intro": "**EstroFrame**ì€ ì‚¬ìš©ìê°€ ì…ë ¥í•œ ë°ì´í„°ë¥¼ ë°”íƒ•ìœ¼ë¡œ í•œ **ìˆ˜í•™ì  ì‹œë®¬ë ˆì´ì…˜ ë„êµ¬**ì…ë‹ˆë‹¤.",
        "landing_disclaimer_item_1": "1. ë³¸ í”„ë¡œê·¸ë¨ì˜ ê²°ê³¼ëŠ” ì‹¤ì œ í˜ˆì•¡ ê²€ì‚¬ ê²°ê³¼ì™€ ë‹¤ë¥¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.",
        "landing_disclaimer_item_2": "2. ì œê³µë˜ëŠ” ì •ë³´ëŠ” **ì˜í•™ì  ì§„ë‹¨ì´ë‚˜ ì²˜ë°©ì„ ëŒ€ì²´í•  ìˆ˜ ì—†ìŠµë‹ˆë‹¤.**",
        "landing_disclaimer_item_3": "3. ì•½ë¬¼ ìš©ëŸ‰ ë³€ê²½ì€ ë°˜ë“œì‹œ ë‹´ë‹¹ ì˜ì‚¬ì™€ ìƒì˜í•´ì•¼ í•©ë‹ˆë‹¤.",
        "landing_disclaimer_question": "ìœ„ ë‚´ìš©ì„ ì´í•´í•˜ì˜€ìœ¼ë©°, ì°¸ê³  ìš©ë„ë¡œë§Œ í™œìš©í•˜ëŠ” ê²ƒì— ë™ì˜í•˜ì‹­ë‹ˆê¹Œ?",
        "landing_agree_btn": "âœ… ë™ì˜í•˜ê³  ì‹œì‘í•˜ê¸°",
        "landing_welcome_title": "ğŸ‘‹ **EstroFrameì— ì˜¤ì‹  ê²ƒì„ í™˜ì˜í•©ë‹ˆë‹¤!**",
        "landing_steps_title": "### ì‹œì‘í•˜ê¸° ìœ„í•œ 3ë‹¨ê³„:",
        "landing_step_1": "1. **ì™¼ìª½ ìƒë‹¨(>)**ì˜ ì‚¬ì´ë“œë°”ë¥¼ ì—¬ì„¸ìš”.",
        "landing_step_2": "2. **[2. ì•½ë¬¼ ì¶”ê°€]** ë©”ë‰´ì—ì„œ í˜„ì¬ íˆ¬ì—¬ ì¤‘ì¸ í˜¸ë¥´ëª¬ì œë¥¼ ì…ë ¥í•˜ì„¸ìš”.",
        "landing_step_3": "3. ì˜ ëª¨ë¥´ì‹œê² ë‹¤ë©´ ì‚¬ì´ë“œë°”ì˜ **'ğŸ£ ì…ë¬¸ ì„¸íŠ¸'** ë²„íŠ¼ì„ ëˆŒëŸ¬ë³´ì„¸ìš”.",
        "landing_demo_btn": "ğŸš€ ë°ëª¨ ë°ì´í„° ë¡œë“œ",
        "start_date_header": "ğŸ—“ï¸ ì‹œì‘ì¼",
        "start_date_label": "ì‹œë®¬ë ˆì´ì…˜/íˆ¬ì—¬ ì‹œì‘ì¼",
        "start_date_help": "ì´ ë‚ ì§œë¥¼ ê¸°ì¤€ìœ¼ë¡œ Day 0ì´ ì„¤ì •ë˜ë©°, ìº˜ë¦°ë” íŒŒì¼(.ics)ì´ ìƒì„±ë©ë‹ˆë‹¤.",
        "edit_scenario": "í¸ì§‘í•  ì‹œë‚˜ë¦¬ì˜¤ ì„ íƒ",
        "scenario_a": "ì‹œë‚˜ë¦¬ì˜¤ A",
        "scenario_b": "ì‹œë‚˜ë¦¬ì˜¤ B",
        "clone_a_to_b": "A â¡ï¸ B ë³µì‚¬",
        "starter_set_caption": "ğŸ£ **ì…ë¬¸ ì„¸íŠ¸**",
        "starter_oral_cpa_btn": "ğŸ’Š ê²½êµ¬+CPA\n(2mg 2íšŒ)",
        "starter_oral_cpa_help": "ê°€ì¥ í”í•œ ê²½êµ¬ ìš”ë²•:\nâ€¢ í”„ë¡œê¸°ë…¸ë°” 2mg (1ì¼ 2íšŒ)\nâ€¢ ì•ˆë“œë¡œì¿¨(CPA) ì²´í¬ë¦¬ìŠ¤íŠ¸ ìë™ ì„ íƒ",
        "starter_oral_cpa_toast": "âœ… ê²½êµ¬ ì…ë¬¸ ì„¸íŠ¸ê°€ ì ìš©ë˜ì—ˆìŠµë‹ˆë‹¤! (CPA ì²´í¬ë¨)",
        "starter_injection_btn": "ğŸ’‰ ì£¼ì‚¬ ìš”ë²•\n(10mg 2ì£¼)",
        "starter_injection_help": "ê°€ì¥ í”í•œ ì£¼ì‚¬ ìš”ë²•:\nâ€¢ ë°í¬ ì£¼ì‚¬ 10mg (2ì£¼ 1íšŒ)",
        "starter_injection_toast": "âœ… ì£¼ì‚¬ ì…ë¬¸ ì„¸íŠ¸ê°€ ì ìš©ë˜ì—ˆìŠµë‹ˆë‹¤!",
        "select_route": "ì œí˜• ì„ íƒ",
        "select_drug": "ì•½ë¬¼ ì„ íƒ",
        "dose_label": "ìš©ëŸ‰ (mg)",
        "freq_mode": "ë³µìš© ë¹ˆë„",
        "freq_qd": "1ì¼ 1íšŒ (QD)",
        "freq_bid": "1ì¼ 2íšŒ (BID)",
        "freq_tid": "1ì¼ 3íšŒ (TID)",
        "freq_custom": "ê¸°íƒ€ (ì¼ ë‹¨ìœ„)",
        "interval_days": "ê°„ê²© (ì¼)",
        "cycle_interval": "ì „ì²´ ì£¼ê¸° (ì¼)",
        "cycle_interval_help": "ì˜ˆ: ì£¼ì‚¬ë¥¼ 14ì¼ë§ˆë‹¤ ë§ëŠ”ë‹¤ë©´ 14 ì…ë ¥",
        "cycling_mode": "íŠ¹ì • ê¸°ê°„ë§Œ ë³µìš©",
        "cycling_mode_help": "ì˜ˆ: ì£¼ì‚¬ ì£¼ê¸° ë§ˆì§€ë§‰ 3ì¼ê°„ë§Œ ê²½êµ¬ì•½ ì¶”ê°€ ë³µìš© ì‹œ ì‚¬ìš©",
        "cycling_example": "ğŸ’¡ ì˜ˆ: 14ì¼ ì£¼ê¸° ì¤‘ 'ë§ˆì§€ë§‰ 3ì¼'ë§Œ ë¨¹ìœ¼ë ¤ë©´ -> ì‹œì‘ì¼: 11, ì§€ì†ì¼: 3",
        "cycle_start_day": "ì‹œì‘ì¼",
        "cycle_duration": "ë³µìš© ì§€ì†ì¼",
        "delete_btn": "ì‚­ì œ",
        "add_schedule_btn": "â• ìŠ¤ì¼€ì¤„ ì¶”ê°€",
        "liver_block_toast": "ê°„ ìˆ˜ì¹˜ ìœ„í—˜ìœ¼ë¡œ ì¸í•´ ì¶”ê°€ê°€ ì°¨ë‹¨ë˜ì—ˆìŠµë‹ˆë‹¤!",
        "added_toast": "ì¶”ê°€ë¨: {name}",
        "current_schedule_header": "í˜„ì¬ ìŠ¤ì¼€ì¤„ ({label})",
        "protocol2_header": "ğŸ“‹ í”„ë¡œí† ì½œ 2: ì²´í¬ë¦¬ìŠ¤íŠ¸",
        "protocol2_caption": "ë³‘ìš© ì¤‘ì¸ ì•½ë¬¼ì„ ì„ íƒí•˜ì„¸ìš”. (ì‹œë®¬ë ˆì´ì…˜ ì œì™¸, ì•ˆì „ì„± ë¶„ì„ìš©)",
        "check_spiro": "ì•Œë‹¥í†¤",
        "check_cpa": "ì•ˆë“œë¡œì¿¨",
        "check_p4": "í”„ë¡œê²ŒìŠ¤í…Œë¡ ",
        "check_gnrh": "ì‚¬ì¶˜ê¸° ì–µì œì œ",
        "interactors_header": "### ğŸ’Š ë³‘ìš© ì•½ë¬¼ ë° ê±´ê°•ë³´ì¡°ì‹í’ˆ",
        "interactors_caption": "í˜„ì¬ ë³µìš© ì¤‘ì¸ ë‹¤ë¥¸ ì•½ë¬¼ì´ë‚˜ ë³´ì¡°ì œê°€ ìˆë‚˜ìš”?",
        "interactors_select": "ë³‘ìš© ì•½ë¬¼ ì„ íƒ (í•­ìƒì œ, í•­ìš°ìš¸ì œ, ìëª½ ë“±)",
        "liver_critical_title": "ğŸš¨ **ì¶”ê°€ ì°¨ë‹¨: ê°„ ìˆ˜ì¹˜ ìœ„ê¸‰**",
        "liver_critical_msg": "AST ë˜ëŠ” ALTê°€ 100 U/L ì´ìƒì¸ ê²½ìš° ê°„ ë…ì„± ìœ„í—˜ìœ¼ë¡œ ì¸í•´ ê²½êµ¬ì œ ì¶”ê°€ê°€ ê¸ˆì§€ë©ë‹ˆë‹¤.",
        "liver_critical_advice": "ğŸ’¡ **ê¶Œì¥ ëŒ€ì•ˆ:** ê°„ ëŒ€ì‚¬ë¥¼ ê±°ì¹˜ì§€ ì•ŠëŠ” **ê²½í”¼ì œ(íŒ¨ì¹˜, ì ¤)** ë˜ëŠ” **ì£¼ì‚¬ì œ**ëŠ” ê°„ì— ì§ì ‘ì ì¸ ë¶€ë‹´ì„ ì£¼ì§€ ì•Šìœ¼ë¯€ë¡œ ë” ì•ˆì „í•œ ì„ íƒì§€ê°€ ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì˜ë£Œì§„ê³¼ ìƒë‹´í•˜ì—¬ ì œí˜• ë³€ê²½ì„ ê²€í† í•´ ë³´ì„¸ìš”.",
        "smoker_label": "í¡ì—°ì",
        "migraine_label": "ì¡°ì§ í¸ë‘í†µ",
        "vte_hist_label": "í˜ˆì „ì¦ ê°€ì¡±ë ¥/ê³¼ê±°ë ¥",
        "route_injection": "ì£¼ì‚¬",
        "route_oral": "ê²½êµ¬",
        "route_transdermal": "ê²½í”¼(íŒ¨ì¹˜/ì ¤)",
        "route_sublingual": "ì„¤í•˜",
        "route_anti_androgen": "í•­ì•ˆë“œë¡œê²",
        "route_progesterone": "í”„ë¡œê²ŒìŠ¤í…Œë¡ ",
        "route_gnrh": "GnRH ì‘ìš©ì œ(ì‚¬ì¶˜ê¸° ì–µì œì œ)",
        "safety_check_title": "ğŸ›¡ï¸ ì„ìƒ ì•ˆì „ì„± ë¶„ì„",
        "search_patient": "ì—…ë¡œë“œëœ í™˜ì ê²€ìƒ‰",
        "load_data_btn": "ë°ì´í„° ë¶ˆëŸ¬ì˜¤ê¸°",
        "update_db_btn": "í˜„ì¬ í™˜ì ì •ë³´ë¥¼ ë©”ëª¨ë¦¬ DBì— ë°˜ì˜",
        "vte_score": "VTE ìœ„í—˜ ì ìˆ˜",
        "vte_level": "í˜„ì¬ ìœ„í—˜ ë“±ê¸‰",
        "model_rel": "ëª¨ë¸ ì‹ ë¢°ë„",
        "unit_choice": "í‘œì‹œ ë‹¨ìœ„",
        "gnrh_agonist": "GnRH-Agonist (ì‚¬ì¶˜ê¸° ì–µì œì œ)",
        "sim_days": "ì‹œë®¬ë ˆì´ì…˜ ê¸°ê°„ (ì¼)",
        "compare_mode": "ğŸ”„ A/B ë¹„êµ ëª¨ë“œ",
        "risk_low": "ë‚®ìŒ",
        "risk_mod": "ë³´í†µ",
        "risk_high": "ë†’ìŒ",
        "risk_vhigh": "ë§¤ìš° ë†’ìŒ",
        "rel_exc": "ë§¤ìš° ì •í™•",
        "rel_good": "ë³´í†µ",
        "rel_poor": "ì¬ë³´ì • í•„ìš”",
        "tanner_stage_msg": "âš ï¸ **[ì²­ì†Œë…„ê¸° ì§€ì¹¨]** WPATH SOC 8ì— ë”°ë¼, ì‚¬ì¶˜ê¸° ë°œë‹¬ ë‹¨ê³„(Tanner Stage 2 ì´ìƒ)ì— ë”°ë¥¸ ì˜ë£Œì§„ì˜ ì •ë°€í•œ ìƒë‹´ê³¼ ì‚¬ì¶˜ê¸° ì–µì œì œ(Puberty Blocker) ê³ ë ¤ê°€ í•„ìš”í•©ë‹ˆë‹¤.",
        "faq_tanner_q": "Q. Tanner Stage(ì‚¬ì¶˜ê¸° ë°œë‹¬ ë‹¨ê³„)ëŠ” ì–´ë–»ê²Œ êµ¬ë¶„í•˜ë‚˜ìš”?",
        "faq_tanner_intro": "Tanner StageëŠ” ì‹ ì²´ì  ì„±ìˆ™ë„ë¥¼ 1ë‹¨ê³„(ì‚¬ì¶˜ê¸° ì´ì „)ë¶€í„° 5ë‹¨ê³„(ì„±ì¸)ê¹Œì§€ ë¶„ë¥˜í•œ í‘œì¤€ ì§€í‘œì…ë‹ˆë‹¤.",
        "tanner_stage": "ë‹¨ê³„",
        "tanner_desc": "ì‹ ì²´ì  íŠ¹ì§• (ìœ ë°© ë°œë‹¬ ì¤‘ì‹¬)",
        "tanner_meaning": "ì„ìƒì  ì˜ë¯¸",
        "tanner_s1_desc": "ğŸŒ‘ **1ë‹¨ê³„**: ì‚¬ì¶˜ê¸° ì´ì „. ìœ ë‘ë§Œ ì•½ê°„ ëŒì¶œëœ ìƒíƒœ.",
        "tanner_s2_desc": "ğŸŒ¸ **2ë‹¨ê³„**: ìœ ë°© ëª½ìš°ë¦¬(Budding) í˜•ì„±. ìœ ë¥œì´ ë„“ì–´ì§€ê¸° ì‹œì‘í•¨.",
        "tanner_s3_desc": "ğŸˆ **3ë‹¨ê³„**: ìœ ë°©ê³¼ ìœ ë¥œì´ ì „ì²´ì ìœ¼ë¡œ ì»¤ì§€ë©° ê²½ê³„ê°€ ëª¨í˜¸í•´ì§.",
        "tanner_s4_desc": "ğŸ’ **4ë‹¨ê³„**: ìœ ë¥œê³¼ ìœ ë‘ê°€ ìœ ë°© ìœ„ë¡œ ì†Ÿì•„ì˜¬ë¼ ì´ì¤‘ ë§ˆìš´ë“œ í˜•ì„±.",
        "tanner_s5_desc": "ğŸ **5ë‹¨ê³„**: ì„±ìˆ™í•œ ë‹¨ê³„. ìœ ë¥œì´ ë‹¤ì‹œ ìœ ë°© ê³¡ì„ ìœ¼ë¡œ í›„í‡´.",
        "tanner_s2_meaning": "**ì‚¬ì¶˜ê¸° ì‹œì‘ / í˜¸ë¥´ëª¬ ì¹˜ë£Œ ê³ ë ¤ ì‹œì **",
        "tanner_s5_meaning": "ì„±ì¸ ìˆ˜ì¤€ì˜ ë°œë‹¬ ì™„ë£Œ",
        "faq_monitor_q": "Q. ì•½ë¬¼ë³„ í•„ìˆ˜ ì¶”ì ê²€ì‚¬ í•­ëª©ì€ ë¬´ì—‡ì¸ê°€ìš”? (Monitoring Checklist)",
        "monitor_table_header_drug": "ì•½ë¬¼êµ°",
        "monitor_table_header_exams": "í•„ìˆ˜/ê¶Œì¥ ê²€ì‚¬ í•­ëª©",
        "monitor_table_header_desc": "ê·¼ê±° ë° ì£¼ì˜ì‚¬í•­",
        "monitor_row_common_drug": "ê³µí†µ (Common)",
        "monitor_row_common_exams": "E2, Total Testosterone",
        "monitor_row_common_desc": "ëª¨ë“  HRT í™˜ìì˜ ê¸°ë³¸ ëª¨ë‹ˆí„°ë§",
        "monitor_row_gnrh_drug": "GnRH Agonist",
        "monitor_row_gnrh_exams": "LH, FSH, DXA (ê³¨ë°€ë„)",
        "monitor_row_gnrh_desc": "ì„±ì„  ìê·¹ ì°¨ë‹¨ í™•ì¸ ë° ê³¨ì†ì‹¤ ê°ì‹œ",
        "monitor_row_spiro_drug": "Spironolactone",
        "monitor_row_spiro_exams": "Electrolytes (K+), Renal Function",
        "monitor_row_spiro_desc": "ê³ ì¹¼ë¥¨í˜ˆì¦ ë° ì‹ ì¥ ê¸°ëŠ¥ ëª¨ë‹ˆí„°ë§",
        "monitor_row_cpa_drug": "CPA (Cyproterone)",
        "monitor_row_cpa_exams": "Prolactin, LFT (ê°„ìˆ˜ì¹˜)",
        "monitor_row_cpa_desc": "í”„ë¡œë½í‹´ ìƒìŠ¹ ë° ê°„ ë…ì„± ì£¼ì˜",
        "monitor_row_p4_drug": "Progesterone",
        "monitor_row_p4_exams": "Lipid Profile, BP, Weight",
        "monitor_row_p4_desc": "ëŒ€ì‚¬ ì§€í‘œ ë° ì‹¬í˜ˆê´€ê³„ ë¦¬ìŠ¤í¬ ê´€ë¦¬",
        "sim_title": "í˜ˆì¤‘ í˜¸ë¥´ëª¬ ë†ë„ ì˜ˆì¸¡",
        "target_range": "ëª©í‘œ ë²”ìœ„",
        "intensive_24h_view": "ğŸ” 48ì‹œê°„ ì§‘ì¤‘ ë³´ê¸°",
        "intensive_24h_help": "í•­ì • ìƒíƒœì—ì„œì˜ ì¼ì£¼ê¸° ë³€ë™ì„±ì„ ìƒì„¸íˆ í™•ì¸í•©ë‹ˆë‹¤.",
        "spike_warning": "ê¸‰ê²©í•œ ë†ë„ ìƒìŠ¹ ê²½ê³ ",
        "high_slope_risk": "ê¸‰ê²©í•œ ë³€í™” ìœ„í—˜",
        "surgery_threshold": "ìˆ˜ìˆ  ì•ˆì „ ê¸°ì¤€ì„ ",
        "graph_title": "ì˜ˆì¸¡ëœ í˜ˆì¤‘ ì—ìŠ¤íŠ¸ë¼ë””ì˜¬ ë†ë„",
        "xaxis_title": "ë‚ ì§œ",
        "stats_title": "ë¶„ì„ í†µê³„",
        "stats_steady_caption": "ğŸ’¡ í†µê³„ ìˆ˜ì¹˜ëŠ” í•­ì • ìƒíƒœ(90~180ì¼) êµ¬ê°„ì„ ê¸°ì¤€ìœ¼ë¡œ ì‚°ì¶œë˜ì—ˆìŠµë‹ˆë‹¤.",
        "monitoring_guide_title": "ğŸ©º ì„ìƒ ì¶”ì ê²€ì‚¬ ê°€ì´ë“œ",
        "monitoring_guide_info": "ğŸ’¡ **ê°€ì´ë“œë¼ì¸:** ì²« í•´ì—ëŠ” ì•½ 3ê°œì›”ë§ˆë‹¤ í‰ê°€í•˜ë©° ìš©ëŸ‰ì„ ì¡°ì ˆí•˜ê³ , ì´í›„ì—ëŠ” ì—° 1~2íšŒ ì •ê¸° ê²€ì‚¬ë¥¼ ê¶Œì¥í•©ë‹ˆë‹¤.",
        "fluctuation_help": "ë³€ë™í­ì´ ì ì„ìˆ˜ë¡ ê°ì • ê¸°ë³µì´ ëœí•©ë‹ˆë‹¤.",
        "max_slope_help": "í•˜ë£¨ ë™ì•ˆ ë°œìƒí•˜ëŠ” ìµœëŒ€ ë†ë„ ë³€í™”ëŸ‰ ({unit}/day)",
        "max_slope_risk_help": "í•˜ë£¨ ë™ì•ˆ ë°œìƒí•˜ëŠ” ìµœëŒ€ ë†ë„ ë³€í™”ëŸ‰ ({unit}/day). 1000 pg/mL/d ì´ˆê³¼ ì‹œ ê°ì • ê¸°ë³µ ìœ„í—˜ì´ í½ë‹ˆë‹¤.",
        "rmse_help": "ì˜ˆì¸¡ ê³¡ì„ ê³¼ ì‹¤ì œ í”¼ê²€ì‚¬ ê²°ê³¼ ê°„ì˜ í‰ê·  ì˜¤ì°¨ì…ë‹ˆë‹¤. ë‚®ì„ìˆ˜ë¡ ëª¨ë¸ì´ ì •í™•í•©ë‹ˆë‹¤.",
        "rmse_na_help": "í”¼ê²€ì‚¬ ê¸°ë¡ì´ ì—†ì–´ ì˜¤ì°¨ë¥¼ ê³„ì‚°í•  ìˆ˜ ì—†ìŠµë‹ˆë‹¤.",
        "rmse_warning_msg": "âš ï¸ **ë†’ì€ ì˜ˆì¸¡ ì˜¤ì°¨ ê°ì§€:** í˜„ì¬ ì‹œë®¬ë ˆì´ì…˜ê³¼ ì‹¤ì œ í”¼ê²€ì‚¬ ê²°ê³¼ ì‚¬ì´ì˜ ì˜¤ì°¨ê°€ í½ë‹ˆë‹¤. [ğŸ§ª í”¼ê²€ì‚¬ ë³´ì •] íƒ­ì—ì„œ ë°ì´í„°ë¥¼ ì¶”ê°€í•˜ê±°ë‚˜ ê³„ìˆ˜ë¥¼ ì¬ì„¤ì •í•˜ì—¬ ì •í™•ë„ë¥¼ ë†’ì—¬ë³´ì„¸ìš”.",
        "calib_notice": "ğŸ’¡ í˜„ì¬ ê·¸ë˜í”„ëŠ” ì‚¬ìš©ì í”¼ê²€ì‚¬ ê²°ê³¼ì— ì˜í•´ ë³´ì •ëœ ìƒíƒœì…ë‹ˆë‹¤.",
        "monotherapy_success": "âœ… **í…ŒìŠ¤í† ìŠ¤í…Œë¡  ì–µì œ ê°€ëŠ¥ êµ¬ê°„(ë‹¨ë…ìš”ë²•):** ì—ìŠ¤íŠ¸ë¡œê² ë†ë„ê°€ ì¶©ë¶„íˆ ë†’ì•„(>200 pg/mL), ë³„ë„ì˜ í•­ë‚¨ì„±í˜¸ë¥´ëª¬ì œ ì—†ì´ë„ í…ŒìŠ¤í† ìŠ¤í…Œë¡  ì–µì œê°€ ê°€ëŠ¥í•  ê²ƒìœ¼ë¡œ ì˜ˆìƒë©ë‹ˆë‹¤.",
        "combo_info": "â„¹ï¸ **ë³‘ìš©ìš”ë²•:** ì—ìŠ¤íŠ¸ë¡œê² ë†ë„ëŠ” ë‹¤ì†Œ ë‚®ì§€ë§Œ(<100 pg/mL), **í•­ë‚¨ì„±í˜¸ë¥´ëª¬ì œ**ë¥¼ ë³‘ìš© ì¤‘ì´ë¯€ë¡œ í…ŒìŠ¤í† ìŠ¤í…Œë¡  ì–µì œ íš¨ê³¼ëŠ” ìœ ì§€ë  ê²ƒì…ë‹ˆë‹¤.",
        "low_estrogen_warning": "âš ï¸ **ì €ì—ìŠ¤íŠ¸ë¡œê² + ì°¨ë‹¨ì œ ì—†ìŒ:** ì—ìŠ¤íŠ¸ë¡œê² ë†ë„ê°€ ë‚®ê³  í•­ë‚¨ì„±í˜¸ë¥´ëª¬ì œë„ ì—†ì–´, í…ŒìŠ¤í† ìŠ¤í…Œë¡  ì–µì œê°€ ë¶ˆì¶©ë¶„í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.",
        "bone_risk": "ğŸ¦´ **ê³¨ë°€ë„ ìœ„í—˜:** ì„±í˜¸ë¥´ëª¬(E2) ìˆ˜ì¹˜ê°€ ë„ˆë¬´ ë‚®ìŠµë‹ˆë‹¤. ì¥ê¸°ê°„ ì§€ì† ì‹œ ê³¨ë‹¤ê³µì¦ ìœ„í—˜ì´ ìˆìŠµë‹ˆë‹¤.",
        "liver_risk": "**[ì£¼ì˜] ê°„ ìˆ˜ì¹˜ ìƒìŠ¹:** í˜„ì¬ AST({ast}) ë˜ëŠ” ALT({alt})ê°€ ì •ìƒ ë²”ìœ„ë¥¼ ì´ˆê³¼í–ˆìŠµë‹ˆë‹¤. ê°„ ê¸°ëŠ¥ ì €í•˜ ì‹œì—ëŠ” ê°„ ëŒ€ì‚¬ë¥¼ ê±°ì¹˜ì§€ ì•ŠëŠ” **ê²½í”¼ì œ(íŒ¨ì¹˜, ì ¤)**ë‚˜ **ì£¼ì‚¬ì œ**ë¡œ ì „í™˜í•˜ëŠ” ê²ƒì´ ê°„ ê±´ê°• ë³´í˜¸ì— ë„ì›€ì´ ë©ë‹ˆë‹¤.",
        "cessation_label": "ì¤‘ë‹¨",
        "resumption_label": "ì¬ê°œ",
        "surgery_date_label": "ìˆ˜ìˆ ì¼",
        "actual_lab_results": "ì‹¤ì œ ê²€ì‚¬ ê²°ê³¼",
        "actual_measure": "ì‹¤ì œ ì¸¡ì •",
        "predicted_e2": "ì˜ˆì¸¡ëœ E2",
        "delta_caption": "ğŸ’¡ ë¸íƒ€(Î”) ê°’ì€ ì‹œë‚˜ë¦¬ì˜¤ B ëŒ€ë¹„ ì°¨ì´ì…ë‹ˆë‹¤.",
        "essential_exam": "â„¹ï¸ **{drug} ë³µìš© ì‹œ í•„ìˆ˜ ê²€ì‚¬:** {exams}",
        "emr_tab_title": "ğŸ“‚ ë³‘ì› í™˜ì ë°ì´í„°ë² ì´ìŠ¤ ê´€ë¦¬",
        "update_db_header": "â• í˜„ì¬ í™˜ìë¥¼ DBì— ì¶”ê°€/ì—…ë°ì´íŠ¸",
        "patient_updated_msg": "'{label}' í™˜ì ì •ë³´ê°€ ì—…ë°ì´íŠ¸ë˜ì—ˆìŠµë‹ˆë‹¤.",
        "mount_db_header": "ğŸ¥ í™˜ì DB ë§ˆìš´íŠ¸",
        "mount_db_caption": "í†µí•© DB(CSV) ë˜ëŠ” ê°œë³„ í™˜ì íŒŒì¼(JSON)ì„ ì—…ë¡œë“œí•˜ì—¬ ì‚¬ì´ë“œë°”ì—ì„œ ê²€ìƒ‰í•  ìˆ˜ ìˆê²Œ í•©ë‹ˆë‹¤.",
        "db_uploader_label": "í™˜ì DB ë˜ëŠ” ê¸°ë¡ ë¬¶ìŒ ì—…ë¡œë“œ",
        "db_mount_merge_default_note": "ê¸°ë³¸ ë™ì‘ì€ ì—…ë¡œë“œ ë°ì´í„°ë¥¼ ê¸°ì¡´ DBì— ë³‘í•©(merge)í•©ë‹ˆë‹¤. ê°™ì€ íŒŒì¼ì€ ìë™ ì¬ì ìš©ë˜ì§€ ì•ŠìŠµë‹ˆë‹¤.",
        "db_mount_replace_btn": "âš ï¸ ì—…ë¡œë“œ ë°ì´í„°ë¡œ DB ì „ì²´ êµì²´",
        "db_mount_mode_applied": "DB ë§ˆìš´íŠ¸ ì ìš©: {mode} / {count}ê±´",
        "mount_success_msg": "í˜„ì¬ {count}ëª…ì˜ í™˜ì ë°ì´í„°ê°€ ë§ˆìš´íŠ¸ë˜ì–´ ìˆìŠµë‹ˆë‹¤.",
        "download_db_btn": "ğŸ“¥ ì „ì²´ í™˜ì DB ë‹¤ìš´ë¡œë“œ (CSV)",
        "load_success_toast": "{name} ë¡œë“œ ì™„ë£Œ",
        "db_select_default": "-- í™˜ì ì„ íƒ --",
        "report_header": "ğŸ“‘ ë¦¬í¬íŠ¸ ë° ì¼ì • ë‚´ë³´ë‚´ê¸°",
        "pdf_section": "ğŸ“„ PDF ë¦¬í¬íŠ¸",
        "pdf_caption": "í˜„ì¬ ì‹œë®¬ë ˆì´ì…˜ ê²°ê³¼ì™€ í”„ë¡œí† ì½œì„ PDFë¡œ ì €ì¥í•©ë‹ˆë‹¤.",
        "pdf_gen_btn": "PDF ìƒì„±",
        "pdf_download_btn": "ğŸ“¥ PDF ë‹¤ìš´ë¡œë“œ",
        "pdf_warn_sim": "ë¨¼ì € ì‹œë®¬ë ˆì´ì…˜ íƒ­ì„ í•œ ë²ˆ í™•ì¸í•´ì£¼ì„¸ìš”.",
        "kaleido_install_hint": "ì„œë²„ í™˜ê²½ ë¬¸ì œì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ë¡œì»¬ì—ì„œ ì‹¤í–‰ ì‹œ 'pip install kaleido'ê°€ í•„ìš”í•©ë‹ˆë‹¤.",
        "ics_section": "ğŸ“… êµ¬ê¸€ ìº˜ë¦°ë” ì¼ì • (.ics)",
        "ics_caption": "íˆ¬ì—¬ ìŠ¤ì¼€ì¤„ì„ ìŠ¤ë§ˆíŠ¸í° ìº˜ë¦°ë”ì— ë“±ë¡í•˜ì„¸ìš”.",
        "ics_download_btn": "ğŸ“… ì¼ì • íŒŒì¼(.ics) ë‹¤ìš´ë¡œë“œ",
        "ics_warn_empty": "ìŠ¤ì¼€ì¤„ì´ ë¹„ì–´ìˆìŠµë‹ˆë‹¤.",
        "json_section": "ğŸ’¾ ë°ì´í„° ê´€ë¦¬ (JSON)",
        "json_caption": "ì„¤ì • ë° ìŠ¤ì¼€ì¤„ì„ íŒŒì¼ë¡œ ë°±ì—…í•˜ê±°ë‚˜ ë¶ˆëŸ¬ì˜µë‹ˆë‹¤.",
        "json_export_btn": "ğŸ’¾ í˜„ì¬ ì„¤ì • ë‚´ë³´ë‚´ê¸°",
        "json_import_label": "ğŸ“‚ ë°ì´í„° ë¶ˆëŸ¬ì˜¤ê¸°",
        "json_load_success": "ë°ì´í„°ë¥¼ ì„±ê³µì ìœ¼ë¡œ ë¶ˆëŸ¬ì™”ìŠµë‹ˆë‹¤.",
        "json_v2_error": "ì´ íŒŒì¼ì€ ì „ì²´ ì„¸ì…˜ ìƒíƒœ(JSON v2.0)ë¥¼ í¬í•¨í•˜ì§€ ì•ŠìŠµë‹ˆë‹¤.",
        "pdf_generated_on": "ìƒì„±ì¼",
        "pdf_profile_title": "1. ì‚¬ìš©ì í”„ë¡œí•„",
        "pdf_protocol_title": "2. íˆ¬ì—¬ í”„ë¡œí† ì½œ",
        "pdf_graph_title": "3. ì‹œë®¬ë ˆì´ì…˜ ë†ë„",
        "pdf_protocol_header": "ì•½ë¬¼ëª… / ì œí˜• / ìš©ëŸ‰ / ì£¼ê¸°",
        "pdf_freq_format": "{dose}mg, {interval}ì¼ë§ˆë‹¤",
        "pdf_disclaimer": "ì£¼ì˜ì‚¬í•­: ì´ ë¦¬í¬íŠ¸ëŠ” ìˆ˜í•™ì  ì‹œë®¬ë ˆì´ì…˜ì´ë©° ì˜í•™ì  ì¡°ì–¸ì´ ì•„ë‹™ë‹ˆë‹¤. í˜ˆì¤‘ ë†ë„ëŠ” ê°œì¸ì— ë”°ë¼ í¬ê²Œ ë‹¤ë¥¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. ë³µìš©ëŸ‰ ë³€ê²½ ì „ ë°˜ë“œì‹œ ì˜ì‚¬ì™€ ìƒë‹´í•˜ì‹­ì‹œì˜¤.",
        "cal_header": "ğŸ§ª ê²½ë¡œë³„ ì •ë°€ ë³´ì •",
        "cal_no_drugs": "ì•½ë¬¼ì„ ë¨¼ì € ì¶”ê°€í•´ì£¼ì„¸ìš”.",
        "cal_lab_day": "ê²€ì‚¬ ì‹œì ",
        "cal_lab_val": "ê²€ì‚¬ ê²°ê³¼ (pg/mL)",
        "cal_target_route": "ì–´ë–¤ íˆ¬ì—¬ ê²½ë¡œë¥¼ ê¸°ì¤€ìœ¼ë¡œ ë³´ì •í• ê¹Œìš”?",
        "cal_injection_caption": "âš ï¸ **ì£¼ì˜:** ì£¼ì‚¬ì œëŠ” íˆ¬ì•½ ì£¼ê¸° ì¤‘ê°„ì˜ ì±„í˜ˆ ê²°ê³¼ê°€ ì¤‘ìš”í•©ë‹ˆë‹¤. ì •í™•í•œ ë³´ì •ì„ ìœ„í•´ íˆ¬ì•½ ì£¼ê¸° ì¤‘ê°„ ì‹œì ì˜ ì±„í˜ˆ ê²°ê³¼ë¥¼ ì…ë ¥í•˜ì„¸ìš”.",
        "cal_oral_caption": "âš ï¸ **ì£¼ì˜:** ë°˜ë“œì‹œ ì•½ ë³µìš© ì§ì „(ìµœì €ì¹˜) ì±„í˜ˆ ê²°ê³¼ë¥¼ ì…ë ¥í•˜ì„¸ìš”. ì•½ ë³µìš© í›„ ì±„í˜ˆí–ˆì„ ê²½ìš° ì˜ˆì¸¡ ì˜¤ì°¨ê°€ í¬ê²Œ ë°œìƒí•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.",
        "cal_target_help": "ì£¼ë¡œ ì‚¬ìš©í•˜ëŠ” ë©”ì¸ íˆ¬ì—¬ ê²½ë¡œë¥¼ ì„ íƒí•˜ì„¸ìš”. ì˜¤ì°¨ì˜ ì›ì¸ì„ í•´ë‹¹ ê²½ë¡œì˜ ëŒ€ì‚¬ ì°¨ì´ë¡œ ê°€ì •í•©ë‹ˆë‹¤.",
        "cal_add_record": "â• ê²€ì‚¬ ê¸°ë¡ ì¶”ê°€",
        "cal_invalid_val": "ìœ íš¨í•œ ê²€ì‚¬ ìˆ˜ì¹˜ë¥¼ ì…ë ¥í•´ì£¼ì„¸ìš”.",
        "cal_success_msg": "âœ… {route} ê¸°ë¡ì´ ì¶”ê°€ë˜ì—ˆìœ¼ë©°, ê°€ì¤‘ í‰ê·  ê³„ìˆ˜ê°€ {k:.2f}ë¡œ ì—…ë°ì´íŠ¸ë˜ì—ˆìŠµë‹ˆë‹¤.",
        "cal_history_title": "#### ğŸ“‹ {route} ê²€ì‚¬ ì´ë ¥",
        "cal_current_factors": "#### í˜„ì¬ ì ìš©ëœ ê°œì¸í™” ê³„ìˆ˜",
        "cal_reset_btn": "ë³´ì • ì´ˆê¸°í™”",
        "day_format": "{day}ì¼",
        "factor_label": "ê³„ìˆ˜",
        "surg_title": "ğŸ¥ ìˆ˜ìˆ  ì „ í˜¸ë¥´ëª¬ ì¤‘ë‹¨ ê³„íš",
        "surg_intro": "ìˆ˜ìˆ (íŠ¹íˆ ì „ì‹ ë§ˆì·¨) ì „ì—ëŠ” í˜ˆì „ ìœ„í—˜ì„ ì¤„ì´ê¸° ìœ„í•´ ì—ìŠ¤íŠ¸ë¡œê² ë³µìš© ì¤‘ë‹¨ì´ ê¶Œì¥ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤.\nì´ê³³ì—ì„œ ì¤‘ë‹¨ ì‹œì ê³¼ ìˆ˜ìˆ ì¼ì˜ ì˜ˆìƒ ë†ë„ë¥¼ ì‹œë®¬ë ˆì´ì…˜í•˜ê³  ì•ˆì „ì„±ì„ í™•ì¸í•˜ì„¸ìš”.",
        "surg_toggle": "ìˆ˜ìˆ  ëª¨ë“œ í™œì„±í™” (ì‹œë®¬ë ˆì´ì…˜ì— ë°˜ì˜)",
        "surg_auto_recommend_label": "ìˆ˜ìˆ ì¼ ê¸°ì¤€ ì¤‘ë‹¨/ì¬ê°œ ìë™ ì¶”ì²œ",
        "surg_recommendation_msg": "ì¶”ì²œ ì¼ì •: ì¤‘ë‹¨ì¼ {stop} / ì¬ê°œì¼ {resume}",
        "surg_type_label": "ìˆ˜ìˆ  ì¢…ë¥˜ ì„ íƒ",
        "rec_cessation": "ê¶Œì¥ ì¤‘ë‹¨ ê¸°ê°„",
        "risk_extension": "ìœ„í—˜êµ° ì—°ì¥ ì ìš©",
        "risk_label": "ìœ„í—˜ë„",
        "first_hrt_date_label": "ìµœì´ˆ í˜¸ë¥´ëª¬ ì¹˜ë£Œ ì‹œì‘ì¼",
        "first_hrt_date_help": "ìˆ˜ìˆ  ê¶Œì¥ ìš”ê±´(WPATH) ë¶„ì„ì„ ìœ„í•´ ì‹¤ì œ í˜¸ë¥´ëª¬ ìš”ë²•ì„ ì²˜ìŒ ì‹œì‘í•œ ë‚ ì§œë¥¼ ì…ë ¥í•˜ì„¸ìš”.",
        "wpath_fail_msg": "ğŸš« **WPATH ê¸°ì¤€ ë¯¸ë‹¬:** ìˆ˜ìˆ ì„ ìœ„í•´ì„œëŠ” ìµœì†Œ {min}ê°œì›”ì˜ í˜¸ë¥´ëª¬ ìš”ë²•ì´ ê¶Œì¥ë©ë‹ˆë‹¤. (í˜„ì¬: ì•½ {curr}ê°œì›”)",
        "wpath_pass_msg": "âœ… **WPATH ê¸°ì¤€ ì¶©ì¡±:** í˜¸ë¥´ëª¬ ìš”ë²• ê¸°ê°„ì´ {curr}ê°œì›”ë¡œ, ìˆ˜ìˆ  ê¶Œì¥ ìš”ê±´ì„ ë§Œì¡±í•©ë‹ˆë‹¤.",
        "high_risk_warn": "âš ï¸ **ê°œì¸ë³„ ìœ„í—˜ë„ ë°˜ì˜:** í™˜ìë¶„ì˜ VTE ìœ„í—˜ ì ìˆ˜ê°€ {level}ì´ë¯€ë¡œ, í‘œì¤€ ì§€ì¹¨ë³´ë‹¤ ë” ê¸´ ì¤‘ë‹¨ ê¸°ê°„ì´ ê¶Œì¥ë©ë‹ˆë‹¤.",
        "vte_eval_title": "ğŸ©¸ ê°œì¸í™”ëœ í˜ˆì „(VTE) ìœ„í—˜ í‰ê°€",
        "risk_factors": "âš ï¸ ì£¼ìš” ìœ„í—˜ ìš”ì¸: {factors}",
        "anesthesia_label": "ë§ˆì·¨ ì¢…ë¥˜",
        "anesthesia_gen": "ì „ì‹ ë§ˆì·¨",
        "anesthesia_local": "êµ­ì†Œë§ˆì·¨",
        "anesthesia_help": "ì „ì‹ ë§ˆì·¨ì˜ ê²½ìš° í˜ˆì „ ìœ„í—˜ìœ¼ë¡œ ì¸í•´ ë” ì—„ê²©í•œ ìˆ˜ì¹˜ ê´€ë¦¬ê°€ í•„ìš”í•©ë‹ˆë‹¤.",
        "date_stop_label": "1. íˆ¬ì•½ ì¤‘ë‹¨ì¼",
        "date_surg_label": "2. ìˆ˜ìˆ  ì˜ˆì •ì¼",
        "date_resume_label": "3. íˆ¬ì•½ ì¬ê°œì¼",
        "resume_date_help": "ì¼ë°˜ì ìœ¼ë¡œ ìˆ˜ìˆ  í›„ ì •ìƒì ì¸ ë³´í–‰ì´ ê°€ëŠ¥í•  ë•Œ ì¬ê°œí•©ë‹ˆë‹¤.",
        "surg_graph_duration_label": "ìˆ˜ìˆ  ê·¸ë˜í”„ ê¸°ê°„ (ì¼)",
        "surg_graph_duration_help": "ìˆ˜ìˆ  íƒ­ì—ì„œ í‘œì‹œ/ë¶„ì„í•  ê¸°ê°„ì…ë‹ˆë‹¤. ê¸°ë³¸ê°’ì€ 'ì¬ê°œì¼ + 30ì¼'ì…ë‹ˆë‹¤.",
        "surg_analysis_title": "ğŸ“‹ ìˆ˜ìˆ  ì¤€ë¹„ ë¶„ì„ ê²°ê³¼",
        "safe_msg": "âœ… **ì•ˆì „: ìˆ˜ìˆ  ì „ ëª©í‘œ ìˆ˜ì¹˜ ë„ë‹¬ ê°€ëŠ¥**",
        "safe_zone": "âœ… ìˆ˜ìˆ  ì•ˆì „ êµ¬ê°„ (< 50 pg/mL)",
        "safe_date_msg": "â€¢ ì˜ˆìƒ ì•ˆì „ ë„ë‹¬ì¼: **{date}**",
        "safe_wait_msg": "â€¢ ì¤‘ë‹¨ í›„ ì•½ **{days:.1f}ì¼** ë’¤ì— 50 pg/mL ì´í•˜ë¡œ ë–¨ì–´ì§‘ë‹ˆë‹¤.",
        "unsafe_msg": "ğŸš« **ì£¼ì˜: ìˆ˜ìˆ ì¼ ì „ê¹Œì§€ ìˆ˜ì¹˜ê°€ ì¶©ë¶„íˆ ë–¨ì–´ì§€ì§€ ì•ŠìŒ**",
        "unsafe_date_msg": "â€¢ ì˜ˆìƒ ì•ˆì „ ë„ë‹¬ì¼({date})ì´ ìˆ˜ìˆ  ì˜ˆì •ì¼ë³´ë‹¤ ëŠ¦ìŠµë‹ˆë‹¤.",
        "unsafe_advice": "ğŸ’¡ íˆ¬ì•½ ì¤‘ë‹¨ì¼ì„ ë” ì•ë‹¹ê¸°ê±°ë‚˜ ì˜ë£Œì§„ê³¼ ìƒë‹´í•˜ì‹­ì‹œì˜¤.",
        "sim_fail_msg": "âš ï¸ ì‹œë®¬ë ˆì´ì…˜ ë²”ìœ„ ë‚´ì—ì„œ ì•ˆì „ ìˆ˜ì¹˜ì— ë„ë‹¬í•˜ì§€ ëª»í–ˆìŠµë‹ˆë‹¤.",
        "resume_guide": "**ğŸ”„ ë³µê·€ ê°€ì´ë“œë¼ì¸:**\n- **ì¬ê°œ ì‹œì :** ìˆ˜ìˆ  í›„ í˜ˆì „ ìœ„í—˜ì´ ê°€ì¥ ë†’ì€ ì‹œê¸°ëŠ” 'ì›€ì§ì´ì§€ ëª»í•˜ëŠ” ê¸°ê°„'ì…ë‹ˆë‹¤. \n- ë³´í†µ ìˆ˜ìˆ  í›„ ìŠ¤ìŠ¤ë¡œ í™”ì¥ì‹¤ì„ ê°€ê±°ë‚˜ ë³µë„ë¥¼ ê±·ëŠ” ë“± **ì¡°ê¸° ë³´í–‰(Early Mobilization)**ì´ ê°€ëŠ¥í•´ì§€ë©´ ì¬ê°œë¥¼ ê³ ë ¤í•©ë‹ˆë‹¤.\n- {surg_name}ì˜ ê²½ìš°, ìˆ˜ìˆ  í›„ ì•½ {weeks} ë‚´ì™¸ì— ì¬ê°œí•˜ëŠ” ê²ƒì´ ì¼ë°˜ì ì´ë‚˜ ë°˜ë“œì‹œ ì§‘ë„ì˜ì™€ ìƒì˜í•˜ì„¸ìš”.",
        "surg_inactive_msg": "ìˆ˜ìˆ  ê³„íšì´ ìˆìœ¼ì‹  ê²½ìš° ìœ„ ìŠ¤ìœ„ì¹˜ë¥¼ ì¼œì„œ ì‹œë®¬ë ˆì´ì…˜ì„ ì‹œì‘í•˜ì„¸ìš”.",
        "bmi_high": "ë†’ì€ BMI",
        "smoker": "í¡ì—°",
        "vte_history": "í˜ˆì „ ê³¼ê±°ë ¥/ê°€ì¡±ë ¥",
        "oral_estrogen": "ê²½êµ¬ì œ ë³µìš©",
        "ì„±í™•ì • ìˆ˜ìˆ  (Vaginoplasty/SRS)": "ì„±í™•ì • ìˆ˜ìˆ ",
        "ê°€ìŠ´ ì„±í˜• (Breast Augmentation)": "ê°€ìŠ´ ì„±í˜•",
        "ì•ˆë©´ ì—¬ì„±í™” ìˆ˜ìˆ  (FFS)": "ì•ˆë©´ ì—¬ì„±í™” ìˆ˜ìˆ ",
        "ê³ í™˜ ì ˆì œìˆ  (Orchiectomy)": "ê³ í™˜ ì ˆì œìˆ ",
        "ê¸°íƒ€ ì „ì‹ ë§ˆì·¨ ìˆ˜ìˆ ": "ê¸°íƒ€ ì „ì‹ ë§ˆì·¨ ìˆ˜ìˆ ",
        "faq_title": "ìì£¼ ë¬»ëŠ” ì§ˆë¬¸ ë° ì°¸ê³  ë¬¸í—Œ",
        "faq_cat_core": "ì›ë¦¬ì™€ ê·¼ê±°",
        "faq_cat_changes": "ë³€í™”ì™€ ë°œë‹¬",
        "faq_cat_safety": "ì•ˆì „ê³¼ ëª¨ë‹ˆí„°ë§",
        "faq_cat_practical": "í•´ì„ê³¼ í™œìš©",
        "faq_intro": "**EstroFrame**ì€ ì˜í•™ì  ê·¼ê±°(Evidence-based)ì— ê¸°ë°˜í•˜ì—¬ ì œì‘ë˜ì—ˆìŠµë‹ˆë‹¤. \nì‚¬ìš©ëœ ìˆ˜ì‹ê³¼ ë°ì´í„°ì˜ ì¶œì²˜ëŠ” ë‹¤ìŒê³¼ ê°™ìŠµë‹ˆë‹¤.",
        "faq_algo_q": "Q. ê·¸ë˜í”„ëŠ” ì–´ë–¤ ì›ë¦¬ë¡œ ê·¸ë ¤ì§€ë‚˜ìš”? (Algorithm)",
        "faq_algo_a": "**1. ì•½ë™í•™ ëª¨ë¸ (Pharmacokinetics):**\në³¸ ì‹œë®¬ë ˆì´í„°ëŠ” **1-Compartment Open Model**ì„ ê¸°ë°˜ìœ¼ë¡œ í•˜ë©°, **Bateman Function**ì„ ì‚¬ìš©í•˜ì—¬ ì•½ë¬¼ì˜ í¡ìˆ˜ì™€ ë°°ì„¤ì„ ê³„ì‚°í•©ë‹ˆë‹¤.\n\n$$ C(t) = \\frac{F \\cdot D \\cdot k_a}{V_d (k_a - k_e)} (e^{-k_e t} - e^{-k_a t}) $$\n\n- **$k_a$ (í¡ìˆ˜ ìƒìˆ˜):** ì•½ë¬¼ì´ í˜ˆë¥˜ë¡œ ë“¤ì–´ê°€ëŠ” ì†ë„ (ì œí˜•ë³„ë¡œ ë‹¤ë¦„)\n- **$k_e$ (ì œê±° ìƒìˆ˜):** ì•½ë¬¼ì´ ëª¸ ë°–ìœ¼ë¡œ ë¹ ì ¸ë‚˜ê°€ëŠ” ì†ë„ (ë°˜ê°ê¸°ì™€ ê´€ë ¨)\n- **$V_d$ (ë¶„í¬ ìš©ì ):** ì•½ë¬¼ì´ ì²´ë‚´ì— í¼ì§€ëŠ” ë¶€í”¼ (ì²´ì¤‘ì— ë¹„ë¡€í•˜ì—¬ ë³´ì •ë¨)\n\n**2. ì¤‘ì²© ì›ë¦¬ (Superposition Principle):**\në°˜ë³µ íˆ¬ì—¬ ì‹œ ì”ì¡´í•˜ëŠ” ì•½ë¬¼ì˜ ë†ë„ë¥¼ ëª¨ë‘ í•©ì‚°í•˜ì—¬, ì‹œê°„ì´ ì§€ë‚ ìˆ˜ë¡ ë†ë„ê°€ ì–´ë–»ê²Œ ìŒ“ì´ëŠ”ì§€(Steady State)ë¥¼ ê³„ì‚°í•©ë‹ˆë‹¤.",
        "faq_ref_q": "Q. ì•½ë¬¼ ë°ì´í„°ì™€ ë°˜ê°ê¸°ëŠ” ì–´ë””ì„œ ê°€ì ¸ì™”ë‚˜ìš”? (References)",
        "faq_ref_a": "ì£¼ìš” ì•½ë¬¼ì˜ ë°˜ê°ê¸°($t_{1/2}$), ìƒì²´ì´ìš©ë¥ ($F$), ì—ìŠ¤í…Œë¥´ ë¬´ê²Œ ë³´ì • ê³„ìˆ˜ëŠ” ì•„ë˜ ë…¼ë¬¸ë“¤ì„ ì°¸ì¡°í–ˆìŠµë‹ˆë‹¤.\n\n**1. Estrogen Pharmacokinetics (General):**\n> *Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(sup1), 3-63.* \n- ì—ìŠ¤íŠ¸ë¼ë””ì˜¬ ë°œë ˆë ˆì´íŠ¸(EV) ë° ê²½êµ¬ ì œì œì˜ ëŒ€ì‚¬ ê²½ë¡œ ì°¸ì¡°.\n\n**2. Injectable Estradiol (Depot):**\n> *Thurmann, P. A., et al. (2005). Pharmacokinetics of estradiol valerate... in healthy postmenopausal women. European Journal of Clinical Pharmacology.* \n- ê·¼ìœ¡ ì£¼ì‚¬(IM) ì‹œì˜ í¡ìˆ˜ íŒ¨í„´ ë° Peak ë„ë‹¬ ì‹œê°„ ì°¸ì¡°.\n\n**3. Transdermal (Gel/Patch):**\n> *Kuhl, H. (1990). Pharmacokinetics of oestrogens and progestogens. Maturitas.* \n- ê²½í”¼ í¡ìˆ˜ì˜ ì¼ì •í•œ ë†ë„ ìœ ì§€ íŠ¹ì„± ì°¸ì¡°.",
        "faq_guide_q": "Q. 'ì ì • ë†ë„'ì™€ 'ìœ„í—˜ ê²½ê³ 'ì˜ ê¸°ì¤€ì€ ë¬´ì—‡ì¸ê°€ìš”?",
        "faq_guide_a": "ì•ˆì „ì„± ê²½ê³  ë° ëª©í‘œ í˜ˆì¤‘ ë†ë„ëŠ” êµ­ì œì ì¸ íŠ¸ëœìŠ¤ì  ë” ë³´ê±´ ê°€ì´ë“œë¼ì¸ì„ ë”°ë¦…ë‹ˆë‹¤.\n\n**1. ëª©í‘œ ë†ë„ (Target Levels):**\n> **WPATH SOC 8 (Standards of Care, Version 8)**\n- íŠ¸ëœìŠ¤ì—¬ì„±ì˜ ê¶Œì¥ E2 ë†ë„: **100 ~ 200 pg/mL**\n- í…ŒìŠ¤í† ìŠ¤í…Œë¡  ì–µì œ ëª©í‘œ: **< 50 ng/dL**\n\n**2. ì•ˆì „ì„± ê²½ê³  (Safety Warnings):**\n> **Endocrine Society Clinical Practice Guideline (2017)**\n- **í˜ˆì „(VTE) ìœ„í—˜:** 35ì„¸ ì´ìƒ í¡ì—°ìì—ê²Œ ê²½êµ¬ ì—ìŠ¤íŠ¸ë¡œê² ì‚¬ìš© ì£¼ì˜ ê¶Œê³ .\n- **í”¼ì„ì•½(EE) ì‚¬ìš© ê¸ˆê¸°:** Ethinyl Estradiolì˜ í˜ˆì „ ìœ„í—˜ì„±ì´ ìƒì²´ë™ë“±ì„± ì œì œë³´ë‹¤ ì›”ë“±íˆ ë†’ìŒì„ ê·¼ê±°ë¡œ ì‚¬ìš© ìì œ ê¶Œê³ .\n\n**3. í•­ë‚¨ì„±í˜¸ë¥´ëª¬ì œ (CPA) ìš©ëŸ‰:**\n> *Agence Nationale de SÃ©curitÃ© du MÃ©dicament (ANSM, France)* & *EMA (Europe)*\n- ì‹œí”„ë¡œí…Œë¡ (Androcur) ì¥ê¸° ê³ ìš©ëŸ‰ ë³µìš© ì‹œ ë‡Œìˆ˜ë§‰ì¢…(Meningioma) ìœ„í—˜ ê²½ê³ ì— ë”°ë¼ ì €ìš©ëŸ‰(10-12.5mg) ê¶Œì¥.",
        "faq_timeline_q": "Q. í˜¸ë¥´ëª¬ ì¹˜ë£Œì— ë”°ë¥¸ ì‹ ì²´ ë³€í™” ì‹œì ì€ ì–¸ì œì¸ê°€ìš”? (WPATH Timeline)",
        "faq_timeline_intro": "WPATH SOC 8 ê°€ì´ë“œë¼ì¸ì— ë”°ë¥¸ ì¼ë°˜ì ì¸ ì‹ ì²´ ë³€í™” íƒ€ì„ë¼ì¸ì…ë‹ˆë‹¤.",
        "timeline_3_6m": "3~6ê°œì›”",
        "timeline_3_6m_desc": "â€¢ ìœ ë°© ëª½ìš°ë¦¬ ì‹œì‘\nâ€¢ í”¼ë¶€ ë¶€ë“œëŸ¬ì›Œì§",
        "timeline_6_12m": "6~12ê°œì›”",
        "timeline_6_12m_desc": "â€¢ ê·¼ìœ¡ëŸ‰ ê°ì†Œ\nâ€¢ ì²´ì§€ë°© ì¬ë°°ì¹˜ (ì—¬ì„±í˜•)",
        "timeline_1_2y": "1~2ë…„+",
        "timeline_1_2y_desc": "â€¢ ìœ ë°© ì„±ì¥ ìµœëŒ€í™”\nâ€¢ ì²´ëª¨ ê°ì†Œ",
        "faq_diff_q": "Q. ì œ í”¼ê²€ì‚¬ ê²°ê³¼ì™€ ì‹œë®¬ë ˆì´ì…˜ì´ ë‹¬ë¼ìš”.",
        "faq_diff_a": "**ë‹¹ì—°í•©ë‹ˆë‹¤.** ì‹œë®¬ë ˆì´ì…˜ì€ 'í‰ê· ì ì¸ ì¸ê°„'ì„ ê°€ì •í•œ ìˆ˜í•™ì  ëª¨ë¸ì…ë‹ˆë‹¤.\nì‹¤ì œë¡œëŠ” ë‹¤ìŒê³¼ ê°™ì€ ìš”ì¸ìœ¼ë¡œ ì°¨ì´ê°€ ë°œìƒí•©ë‹ˆë‹¤:\n\n- **ìœ ì „ì  ëŒ€ì‚¬ ì°¨ì´:** ê°„ íš¨ì†Œ(CYP3A4 ë“±) í™œì„±ë„ëŠ” ì‚¬ëŒë§ˆë‹¤ ë‹¤ë¦…ë‹ˆë‹¤.\n- **ì²´ì§€ë°©ë¥ :** ì—ìŠ¤íŠ¸ë¡œê²ì€ ì§€ë°©ì„¸í¬ì— ì €ì¥ë˜ì—ˆë‹¤ê°€ ì„œì„œíˆ ë°©ì¶œë˜ê¸°ë„ í•©ë‹ˆë‹¤.\n- **SHBG (ì„±í˜¸ë¥´ëª¬ ê²°í•© ê¸€ë¡œë¶ˆë¦°):** ì´ ì—ìŠ¤íŠ¸ë¼ë””ì˜¬(Total E2) ì¤‘ ì‹¤ì œ í™œì„±í˜•(Free E2)ì˜ ë¹„ìœ¨ì„ ê²°ì •í•©ë‹ˆë‹¤.\n\nğŸ‘‰ **[í”¼ê²€ì‚¬ ë³´ì •] íƒ­**ì„ ì‚¬ìš©í•˜ì—¬ ìì‹ ì˜ ê²€ì‚¬ ê²°ê³¼ë¥¼ ì…ë ¥í•˜ë©´, ì‹œë®¬ë ˆì´í„°ê°€ ê°œì¸ì°¨ë¥¼ ë°˜ì˜í•˜ì—¬ ê·¸ë˜í”„ë¥¼ ìˆ˜ì •í•´ ì¤ë‹ˆë‹¤.",
        "faq_units_q": "Q. pg/mLì™€ pmol/LëŠ” ë¬´ì—‡ì´ ë‹¤ë¥¸ê°€ìš”?",
        "faq_units_a": "ë‘ ê°’ì€ **ê°™ì€ ë†ë„**ë¥¼ ë‹¤ë¥¸ ë‹¨ìœ„ë¡œ í‘œí˜„í•œ ê²ƒì…ë‹ˆë‹¤.\n\n- pg/mL: ì§ˆëŸ‰ ê¸°ë°˜ ë‹¨ìœ„\n- pmol/L: ë¶„ì ìˆ˜(ëª°) ê¸°ë°˜ ë‹¨ìœ„\n\nEstroFrameì—ì„œëŠ” ìë™ ë³€í™˜ì„ ì§€ì›í•˜ë©°, ì—ìŠ¤íŠ¸ë¼ë””ì˜¬(E2) ê¸°ì¤€ìœ¼ë¡œ **1 pg/mL â‰ˆ 3.6713 pmol/L**ë¥¼ ì‚¬ìš©í•©ë‹ˆë‹¤.",
        "faq_compare_q": "Q. A/B ë¹„êµ ëª¨ë“œëŠ” ì–´ë–»ê²Œ ì½ìœ¼ë©´ ë˜ë‚˜ìš”?",
        "faq_compare_a": "A/B ëª¨ë“œëŠ” ë‘ ìŠ¤ì¼€ì¤„ì˜ ì°¨ì´ë¥¼ ë¹ ë¥´ê²Œ ë³´ëŠ” ê¸°ëŠ¥ì…ë‹ˆë‹¤.\n\n- ê°™ì€ ê¸°ê°„/ê°™ì€ ë‹¨ìœ„ì—ì„œ ë‘ ê³¡ì„ ì„ ë¹„êµí•˜ì„¸ìš”.\n- í†µê³„ ì¹´ë“œì˜ Î”ê°’ì€ **A ê¸°ì¤€ B ëŒ€ë¹„ ì°¨ì´**ë¥¼ ì˜ë¯¸í•©ë‹ˆë‹¤.\n- Peakë§Œ ë³´ì§€ ë§ê³ , **TroughÂ·FluctuationÂ·Max Slope**ë¥¼ í•¨ê»˜ í™•ì¸í•˜ëŠ” ê²ƒì´ ì¤‘ìš”í•©ë‹ˆë‹¤.",
        "faq_surgery_plan_q": "Q. ìˆ˜ìˆ  íƒ­ì˜ ì¤‘ë‹¨/ìˆ˜ìˆ /ì¬ê°œ ì¼ì •ì€ ì–´ë–»ê²Œ í•´ì„í•˜ë‚˜ìš”?",
        "faq_surgery_plan_a": "ìˆ˜ìˆ  íƒ­ì€ ìˆ˜ìˆ ì¼ ì „í›„ ì•ˆì „ ë²”ìœ„ë¥¼ í™•ì¸í•˜ê¸° ìœ„í•œ ë„êµ¬ì…ë‹ˆë‹¤.\n\n- **ì¤‘ë‹¨ì¼:** íˆ¬ì•½ì„ ë©ˆì¶”ëŠ” ë‚ ì§œ\n- **ìˆ˜ìˆ ì¼:** ëª©í‘œ ì•ˆì „ë†ë„ ë„ë‹¬ ì—¬ë¶€ë¥¼ í™•ì¸í•˜ëŠ” ê¸°ì¤€ì¼\n- **ì¬ê°œì¼:** ë³´í–‰ íšŒë³µ ë“± ì„ìƒ ìƒíƒœë¥¼ ê³ ë ¤í•´ ë‹¤ì‹œ ì‹œì‘í•˜ëŠ” ë‚ ì§œ\n\nì•ˆì „ ë„ë‹¬ì¼ì´ ìˆ˜ìˆ ì¼ë³´ë‹¤ ëŠ¦ê²Œ ë‚˜ì˜¤ë©´ ì¤‘ë‹¨ì¼ì„ ì•ë‹¹ê¸°ëŠ” ë°©í–¥ì„ ê²€í† í•˜ì„¸ìš”.",
        "faq_data_privacy_q": "Q. ë‚´ ë°ì´í„°ëŠ” ì–´ë””ì— ì €ì¥ë˜ë‚˜ìš”? (ê°œì¸ì •ë³´/ë³´ì•ˆ)",
        "faq_data_privacy_a": "ê¸°ë³¸ì ìœ¼ë¡œ ë°ì´í„°ëŠ” í˜„ì¬ ì„¸ì…˜(ë¸Œë¼ìš°ì €/ì•± ì‹¤í–‰ ìƒíƒœ)ì—ì„œ ì‚¬ìš©ë©ë‹ˆë‹¤.\n\n- JSON/PDF/ICSë¥¼ ë‚´ë³´ë‚¼ ë•Œë§Œ ì‚¬ìš©ìê°€ ì„ íƒí•œ ìœ„ì¹˜ì— íŒŒì¼ì´ ì €ì¥ë©ë‹ˆë‹¤.\n- íŒŒì¼ ì—…ë¡œë“œ/ë¶ˆëŸ¬ì˜¤ê¸°ëŠ” ì‚¬ìš©ìì˜ ë¡œì»¬ ì‘ì—… íë¦„ì„ ê¸°ì¤€ìœ¼ë¡œ ë™ì‘í•©ë‹ˆë‹¤.\n- ë¯¼ê° ì •ë³´ëŠ” ê³µìœ  ì „ íŒŒì¼ ë‚´ìš©ì„ ì§ì ‘ í™•ì¸í•˜ê³  ë¶ˆí•„ìš”í•œ í•­ëª©ì„ ì œê±°í•˜ëŠ” ê²ƒì„ ê¶Œì¥í•©ë‹ˆë‹¤.",
        "faq_doctor_q": "Q. ì´ ê²°ê³¼ë¥¼ ì˜ì‚¬ ì„ ìƒë‹˜ê»˜ ë³´ì—¬ë“œë ¤ë„ ë˜ë‚˜ìš”?",
        "faq_doctor_a": "**ë„¤, ê°€ëŠ¥í•©ë‹ˆë‹¤.** [ë¦¬í¬íŠ¸] íƒ­ì—ì„œ PDFë¥¼ ì¶œë ¥í•˜ì—¬ ìƒë‹´ ì‹œ ì°¸ê³  ìë£Œë¡œ í™œìš©í•˜ì„¸ìš”. \në‹¨, ì´ í”„ë¡œê·¸ë¨ì€ ì˜ë£Œ ê¸°ê¸°ê°€ ì•„ë‹ˆë©°, ì˜ì‚¬ì˜ ì²˜ë°©ì„ ëŒ€ì²´í•  ìˆ˜ ì—†ìŒì„ ëª…ì‹¬í•´ ì£¼ì„¸ìš”.",
        "faq_slope_q": "Q. ê¸‰ê²©í•œ ë³€í™” ê²½ê³ (100 pg/mL/d)ì˜ ê¸°ì¤€ì€ ë¬´ì—‡ì¸ê°€ìš”?",
        "faq_slope_a": "ì´ëŠ” ì—¬ì„±ì˜ ìì—°ì ì¸ ì›”ê²½ ì£¼ê¸° ì¤‘ ì—ìŠ¤íŠ¸ë¡œê²ì´ ê°€ì¥ ê¸‰ê²©íˆ ë³€í•˜ëŠ” ë°°ë€ê¸°ì˜ ì†ë„(Physiological Limit)ë¥¼ ì°¸ê³ í•˜ì—¬ ì„¤ì •ëœ ì•ˆì „ ê¸°ì¤€ì…ë‹ˆë‹¤. ì´ ì†ë„ë¥¼ ì´ˆê³¼í•  ê²½ìš° ë‡Œì˜ ì‹ ê²½ì „ë‹¬ë¬¼ì§ˆì´ ì ì‘í•˜ì§€ ëª»í•´ ê¸°ë¶„ ë³€í™”(Mood Swing)ê°€ ë°œìƒí•  ê°€ëŠ¥ì„±ì´ ë†’ì•„ì§‘ë‹ˆë‹¤. (Estrogen Withdrawal Theory)",
        "faq_high_e2_q": "Q. ì—ìŠ¤íŠ¸ë¡œê² ìˆ˜ì¹˜ê°€ ë†’ì„ìˆ˜ë¡ ì¢‹ì€ ê²ƒ ì•„ë‹Œê°€ìš”? (Supraphysiological Levels)",
        "faq_high_e2_a": "**ì•„ë‹™ë‹ˆë‹¤. 'ë‹¤ë‹¤ìµì„ 'ì´ ì ìš©ë˜ì§€ ì•ŠìŠµë‹ˆë‹¤.**\n\nì§€ë‚˜ì¹˜ê²Œ ë†’ì€ ë†ë„(Supraphysiological levels)ëŠ” ë‹¤ìŒê³¼ ê°™ì€ ë¬¸ì œë¥¼ ì¼ìœ¼í‚¬ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n\n**1. í˜ˆì „(VTE) ìœ„í—˜ ì¦ê°€:**\n- ì—ìŠ¤íŠ¸ë¡œê² ë†ë„ê°€ ì„ì‹  ë§ê¸° ìˆ˜ì¤€(ìˆ˜ì²œ pg/mL)ìœ¼ë¡œ ì¹˜ì†Ÿìœ¼ë©´, ê°„ì„ ìê·¹í•˜ì—¬ í˜ˆì•¡ ì‘ê³  ì¸ì ìƒì„±ì„ ì´‰ì§„í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤. íŠ¹íˆ í¡ì—°ìë‚˜ ê³ ë ¹ìì—ê²Œ ì¹˜ëª…ì ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.\n\n**2. ê¸°ë¶„ ë³€í™” (Mood Swings):**\n- **'ë¡¤ëŸ¬ì½”ìŠ¤í„° íš¨ê³¼'**ë¥¼ ì£¼ì˜í•˜ì„¸ìš”. ë†ë„ê°€ ë†’ì´ ì˜¬ë¼ê°ˆìˆ˜ë¡, ë–¨ì–´ì§ˆ ë•Œì˜ ë‚™ì°¨ë„ í½ë‹ˆë‹¤. ê¸‰ê²©í•œ í˜¸ë¥´ëª¬ í•˜ë½ì€ ë‡Œì˜ ì‹ ê²½ì „ë‹¬ë¬¼ì§ˆ ê· í˜•ì„ ê¹¨ëœ¨ë ¤ ì‹¬í•œ ìš°ìš¸ê°ì´ë‚˜ ë‘í†µì„ ìœ ë°œí•©ë‹ˆë‹¤.\n\n**3. SHBG (ì„±í˜¸ë¥´ëª¬ ê²°í•© ê¸€ë¡œë¶ˆë¦°) ì¦ê°€:**\n- ìš°ë¦¬ ëª¸ì€ ì—ìŠ¤íŠ¸ë¡œê²ì´ ë„ˆë¬´ ë§ìœ¼ë©´ ì´ë¥¼ ë¬¶ì–´ë‘ê¸° ìœ„í•´ SHBGë¼ëŠ” ë‹¨ë°±ì§ˆì„ ëŠ˜ë¦½ë‹ˆë‹¤. ì´ ê²½ìš° ì´(Total) ì—ìŠ¤íŠ¸ë¡œê²ì€ ë†’ê²Œ ì¸¡ì •ë˜ì§€ë§Œ, ì •ì‘ íš¨ê³¼ë¥¼ ë‚´ëŠ” **ììœ (Free) ì—ìŠ¤íŠ¸ë¡œê²**ì€ ì¤„ì–´ë“¤ì–´ ì—¬ì„±í™” íš¨ìœ¨ì´ ë–¨ì–´ì§ˆ ìˆ˜ ìˆìŠµë‹ˆë‹¤.",
        "safe_center_title": "ğŸš‘ ì•ˆì „ ë° ì‘ê¸‰ ëŒ€ì²˜",
        "emergency_self_check_title": "ğŸš¨ ì‘ê¸‰ ì¦ìƒ ìê°€ ì§„ë‹¨",
        "emergency_self_check_caption": "í˜ˆì „ì¦(VTE) ì˜ì‹¬ ì¦ìƒ ë°œìƒ ì‹œ ì¦‰ì‹œ íˆ¬ì—¬ë¥¼ ì¤‘ë‹¨í•˜ê³  ë³‘ì›ì„ ë°©ë¬¸í•˜ì„¸ìš”.",
        "dvt_title": "#### ğŸ¦µ ì‹¬ë¶€ì •ë§¥í˜ˆì „ì¦",
        "dvt_symptoms": "- **í•˜ì§€ ë¶€ì¢…:** í•œìª½ ë‹¤ë¦¬ê°€ ëˆˆì— ë„ê²Œ ë¶“ìŒ\n- **í†µì¦:** ì¢…ì•„ë¦¬ì— ì¥ê°€ ë‚œ ë“¯í•œ í†µì¦ì´ë‚˜ ì••í†µ\n- **ì—´ê°/ë°œì :** í•´ë‹¹ ë¶€ìœ„ê°€ ëœ¨ê²ê±°ë‚˜ ë¶‰ê²Œ ë³€í•¨",
        "pe_title": "#### ğŸ« íìƒ‰ì „ì¦ - ì¦‰ì‹œ 119 ì‹ ê³ ",
        "pe_symptoms": "- **í˜¸í¡ ê³¤ë€:** ê°‘ì‘ìŠ¤ëŸ¬ìš´ ìˆ¨ê°€ì¨\n- **í‰í†µ:** ìˆ¨ì„ ê¹Šê²Œ ì‰´ ë•Œ ì°Œë¥´ëŠ” ë“¯í•œ ê°€ìŠ´ í†µì¦\n- **ê°í˜ˆ:** ê¸°ì¹¨ ì‹œ í”¼ê°€ ì„ì—¬ ë‚˜ì˜´\n- **ë¹ˆë§¥:** ë§¥ë°•ì´ ì´ìœ  ì—†ì´ ë¹¨ë¼ì§",
        "safe_center_tip": "ğŸ’¡ **ì°¸ê³ :** ìœ„ ì¦ìƒì€ í˜¸ë¥´ëª¬ ìš”ë²•ì˜ ê°€ì¥ ì‹¬ê°í•œ ë¶€ì‘ìš©ì…ë‹ˆë‹¤. íŠ¹íˆ **í¡ì—°ì**ë‚˜ **ìˆ˜ìˆ  ì§í›„** í™˜ìëŠ” ê°ë³„íˆ ì£¼ì˜í•´ì•¼ í•©ë‹ˆë‹¤.",
        "feminization_progress_title": "ğŸŒ¸ ì—¬ì„±í™” ì§„í–‰ë„",
        "feminization_current_status": "ğŸ“ **í˜„ì¬ ìƒíƒœ:** {stage}",
        "missed_title": "ğŸš‘ ì‘ê¸‰ì²˜ì¹˜: ì•½ì„ ë†“ì³¤ë‚˜ìš”?",
        "missed_caption": "ë³µìš©(íˆ¬ì—¬) ì‹œê¸°ë¥¼ ë†“ì³¤ì„ ë•Œ ì–´ë–»ê²Œ í•´ì•¼ í• ì§€ ì•Œë ¤ë“œë¦½ë‹ˆë‹¤.",
        "missed_add_drug_first": "ë¨¼ì € ì•½ë¬¼ì„ ì¶”ê°€í•´ì£¼ì„¸ìš”.",
        "missed_select_drug": "ë†“ì¹œ ì•½ë¬¼ ì„ íƒ",
        "missed_last_date": "ë§ˆì§€ë§‰ ë³µìš© ë‚ ì§œ",
        "missed_last_time": "ë§ˆì§€ë§‰ ë³µìš© ì‹œê°„",
        "missed_calc_btn": "ê²°ê³¼ í™•ì¸",
        "missed_future_error": "ë¯¸ë˜ì˜ ì‹œê°„ì„ ì…ë ¥í•  ìˆ˜ ì—†ìŠµë‹ˆë‹¤.",
        "missed_take_now_label": "âœ… **ì¦‰ì‹œ ë³µìš©í•˜ì„¸ìš”**",
        "missed_skip_label": "â›” **ê±´ë„ˆë›°ì„¸ìš”**",
        "missed_next_due": "ğŸ“… ì›ë˜ ë‹¤ìŒ ì˜ˆì •ì¼: {next}",
        "dev_credit": "Developed by **Jisong** (Medical Student) | Contact: jsbang01357@gmail.com",
        "risk_vte_smoker": "**[ì‹¬ê°] 35ì„¸ ì´ìƒ í¡ì—°ìì˜ ê²½êµ¬ ì—ìŠ¤íŠ¸ë¡œê² íˆ¬ì—¬**ëŠ” í˜ˆì „(VTE) ìœ„í—˜ì„ ê¸°í•˜ê¸‰ìˆ˜ì ìœ¼ë¡œ ë†’ì…ë‹ˆë‹¤. íŒ¨ì¹˜ë‚˜ ì ¤(Transdermal)ë¡œì˜ ì „í™˜ì´ ê°•ë ¥íˆ ê¶Œê³ ë©ë‹ˆë‹¤.",
        "risk_vte_history": "**[ìœ„í—˜] í˜ˆì „ ê³¼ê±°ë ¥**ì´ ìˆëŠ” ê²½ìš° ê²½êµ¬ ì œì œëŠ” í”¼í•´ì•¼ í•©ë‹ˆë‹¤. ê²½í”¼ì œ(Transdermal)ê°€ ë” ì•ˆì „í•©ë‹ˆë‹¤.",
        "risk_migraine": "**[ì£¼ì˜] ì¡°ì§ í¸ë‘í†µ**ì´ ìˆëŠ” ê²½ìš° ê²½êµ¬ ì—ìŠ¤íŠ¸ë¡œê²ì€ ë‡Œì¡¸ì¤‘ ìœ„í—˜ì„ ë†’ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.",
        "risk_dose_dumping": "**[ì£¼ì˜] {label}ê¸‰ê²©í•œ ë†ë„ ìŠ¤íŒŒì´í¬ ê°ì§€:** ìµœê³  ë†ë„ê°€ {limit} pg/mLë¥¼ ì´ˆê³¼í–ˆìŠµë‹ˆë‹¤. ì´ëŠ” ê·¹ì‹¬í•œ ê¸°ë¶„ ë³€í™”, ë‘í†µ, ë©”ìŠ¤êº¼ì›€ì„ ìœ ë°œí•  ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì„¤í•˜ íˆ¬ì—¬ ì‹œ ë¶„í•  ë³µìš©ì„ ê³ ë ¤í•˜ê±°ë‚˜ ìš©ëŸ‰ ì¡°ì ˆì´ í•„ìš”í•©ë‹ˆë‹¤.",
        "reason_low_trough": "ìµœì € ë†ë„ê°€ 50 pg/mL ë¯¸ë§Œ",
        "risk_estrogen_super_high": "**[ê²½ê³ ] ì´ˆê³ ë†ë„ ì—ìŠ¤íŠ¸ë¡œê²:** í˜ˆì¤‘ ë†ë„ê°€ ìƒë¦¬ì  ë²”ìœ„ë¥¼ í¬ê²Œ ì´ˆê³¼í–ˆìŠµë‹ˆë‹¤. íˆ¬ì—¬ ê²½ë¡œì™€ ë¬´ê´€í•˜ê²Œ í˜ˆì•¡ ì‘ê³ (í˜ˆì „) ìœ„í—˜ì´ ì¦ê°€í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.",
        "reason_high_slope": "ë†ë„ ë³€í™”ê°€ ë§¤ìš° ê¸‰ê²©í•¨",
        "risk_mood_swing": "**[ì£¼ì˜] ê°ì • ë³€í™” ê°€ëŠ¥ì„±:** {reasons}ìœ¼ë¡œ ì¸í•´ ìš°ìš¸ê°, ë¬´ê¸°ë ¥ì¦, ê·¹ì‹¬í•œ ê¸°ë¶„ ê¸°ë³µì´ ë°œìƒí•  ìˆ˜ ìˆìŠµë‹ˆë‹¤. íˆ¬ì—¬ ê°„ê²©ì„ ì¢íˆê±°ë‚˜ ì œí˜• ë³€ê²½ì„ ê³ ë ¤í•´ ë³´ì„¸ìš”.",
        "ddi_inhibitor_title": "âš ï¸ ë†ë„ ìƒìŠ¹ ì£¼ì˜ ({med_name})",
        "ddi_inhibitor_msg": "{med_name}ì€(ëŠ”) ì—ìŠ¤íŠ¸ë¡œê² ëŒ€ì‚¬ë¥¼ ì–µì œí•˜ì—¬ í˜ˆì¤‘ ë†ë„ë¥¼ ë†’ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. (ê¸‰ê²©í•œ ë†ë„ ìƒìŠ¹ ìœ„í—˜)",
        "ddi_inducer_title": "ğŸ“‰ íš¨ê³¼ ê°ì†Œ ê²½ê³  ({med_name})",
        "ddi_inducer_msg": "{med_name}ì€(ëŠ”) ê°„ íš¨ì†Œë¥¼ ìœ ë„í•˜ì—¬ ì—ìŠ¤íŠ¸ë¡œê²ì„ ë¹ ë¥´ê²Œ ë¶„í•´í•©ë‹ˆë‹¤. ëª©í‘œ ë†ë„ì— ë„ë‹¬í•˜ì§€ ëª»í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤.",
        "ddi_spiro_title": "ğŸš¨ ê³ ì¹¼ë¥¨í˜ˆì¦ ìœ„í—˜ ({med_name})",
        "ddi_spiro_msg": "ìŠ¤í”¼ë¡œë…¸ë½í†¤ê³¼ {med_name} ë³‘ìš© ì‹œ ì¹˜ëª…ì ì¸ ê³ ì¹¼ë¥¨í˜ˆì¦(ë¶€ì •ë§¥ ë“±) ìœ„í—˜ì´ ìˆìŠµë‹ˆë‹¤. ë°˜ë“œì‹œ ì˜ì‚¬ì™€ ìƒì˜í•˜ì„¸ìš”.",
        "risk_p4_side_effect": "âš ï¸ **[ì£¼ì˜] í”„ë¡œê²ŒìŠ¤í…Œë¡  ë³µìš© ì¤‘:** ì¡¸ìŒ, ì–´ì§€ëŸ¬ì›€, ìœ ë°© í†µì¦ ë˜ëŠ” ë¶€ì¢…ì´ ë‚˜íƒ€ë‚  ìˆ˜ ìˆìŠµë‹ˆë‹¤. ì¡¸ìŒ ë°©ì§€ë¥¼ ìœ„í•´ ì·¨ì¹¨ ì „ ë³µìš©ì´ ê¶Œì¥ë©ë‹ˆë‹¤.",
        "ts_1_label": "íƒœë„ˆ ë‹¨ê³„ 1 (ì´ˆê¸°)",
        "ts_1_desc": "ì‹ ì²´ ë³€í™”ê°€ ë§‰ ì‹œì‘ë˜ëŠ” ë‹¨ê³„ì…ë‹ˆë‹¤.",
        "ts_2_label": "íƒœë„ˆ ë‹¨ê³„ 2 (ë°œì•„ê¸°)",
        "ts_2_desc": "ìœ ë°© ëª½ìš°ë¦¬ í˜•ì„±ì´ ì‹œì‘ë˜ëŠ” ì‹œê¸°ì…ë‹ˆë‹¤.",
        "ts_3_label": "íƒœë„ˆ ë‹¨ê³„ 3 (ì„±ì¥ê¸°)",
        "ts_3_desc": "ì§€ë°© ì¬ë°°ì¹˜ì™€ ìœ ë°© ë°œë‹¬ì´ ê°€ì†í™”ë©ë‹ˆë‹¤.",
        "ts_4_label": "íƒœë„ˆ ë‹¨ê³„ 4 (ì„±ìˆ™ê¸°)",
        "ts_4_desc": "ì—¬ì„±ì ì¸ ì²´í˜•ì´ ëšœë ·í•´ì§€ëŠ” ì‹œê¸°ì…ë‹ˆë‹¤.",
        "ts_5_label": "íƒœë„ˆ ë‹¨ê³„ 5 (ì™„ì„±ê¸°)",
        "ts_5_desc": "ì‹ ì²´ ë³€í™”ê°€ ì™„ì„± ë‹¨ê³„ì— ë„ë‹¬í–ˆìŠµë‹ˆë‹¤.",
        "missed_overdue_msg": "ì˜ˆì •ëœ ì‹œê°„ì„ ì´ë¯¸ ì§€ë‚¬ìŠµë‹ˆë‹¤. ìƒê°ë‚œ ì¦‰ì‹œ ë³µìš©(íˆ¬ì—¬)í•˜ì‹œê³ , ê·¸ ë‹¤ìŒ íˆ¬ì—¬ëŠ” ì´ë²ˆ íˆ¬ì—¬ ì‹œì ì„ ê¸°ì¤€ìœ¼ë¡œ ê°„ê²©ì„ ë‹¤ì‹œ ì„¤ì •í•˜ì„¸ìš”.",
        "missed_skip_msg": "ë‹¤ìŒ íˆ¬ì—¬ê¹Œì§€ ì•½ **{hours_left:.1f}ì‹œê°„**ë°–ì— ë‚¨ì§€ ì•Šì•˜ìŠµë‹ˆë‹¤. (ê°„ê²©ì˜ 50% ë¯¸ë§Œ)\nì§€ê¸ˆ ë“œì‹œë©´ ê³¼ë‹¤ íˆ¬ì—¬ ìœ„í—˜ì´ ìˆìœ¼ë‹ˆ **ì´ë²ˆ íšŒì°¨ëŠ” ê±´ë„ˆë›°ê³ (Skip)**, ë‹¤ìŒ ì˜ˆì •ëœ ì‹œê°„ì— ì •ëŸ‰ì„ ë³µìš©í•˜ì„¸ìš”.",
        "missed_take_msg": "ì•„ì§ ë‹¤ìŒ íˆ¬ì—¬ê¹Œì§€ ì¶©ë¶„í•œ ì‹œê°„ì´ ë‚¨ì•˜ìŠµë‹ˆë‹¤. \n**ìƒê°ë‚œ ì¦‰ì‹œ ë³µìš©(íˆ¬ì—¬)**í•˜ì‹œê³ , ë‹¤ìŒ íˆ¬ì—¬ëŠ” ì›ë˜ ì˜ˆì •ëŒ€ë¡œ ì§„í–‰í•˜ì…”ë„ ì¢‹ìŠµë‹ˆë‹¤.",
        "fmt_months": "{months:.1f}ê°œì›” ({days}ì¼)",
        "fmt_weeks": "{weeks:.1f}ì£¼ ({days}ì¼)",
        "fmt_days": "{days}ì¼",
        "faq_algo_summary": "ìš”ì•½: ì•½ë™í•™ ê³µì‹ê³¼ ì¤‘ì²© ì›ë¦¬ë¡œ ì‹œê°„ë³„ ë†ë„ ë³€í™”ë¥¼ ê³„ì‚°í•©ë‹ˆë‹¤.",
        "faq_ref_summary": "ìš”ì•½: ì£¼ìš” ìˆ˜ì¹˜ì™€ ëª¨ë¸ íŒŒë¼ë¯¸í„°ëŠ” ê³µê°œëœ ì•½ë™í•™ ë¬¸í—Œì„ ê¸°ë°˜ìœ¼ë¡œ í•©ë‹ˆë‹¤.",
        "faq_guide_summary": "ìš”ì•½: ëª©í‘œ ë²”ìœ„ì™€ ê²½ê³  ê¸°ì¤€ì€ WPATH/Endocrine ê°€ì´ë“œë¼ì¸ì„ ë”°ë¦…ë‹ˆë‹¤.",
        "faq_timeline_summary": "ìš”ì•½: ë³€í™”ëŠ” ë³´í†µ ìˆ˜ê°œì›”~ìˆ˜ë…„ì— ê±¸ì³ ì ì§„ì ìœ¼ë¡œ ì§„í–‰ë©ë‹ˆë‹¤.",
        "faq_tanner_summary": "ìš”ì•½: Tanner StageëŠ” ì‚¬ì¶˜ê¸° ë°œë‹¬ ì •ë„ë¥¼ ê°ê´€ì ìœ¼ë¡œ êµ¬ë¶„í•˜ëŠ” ì§€í‘œì…ë‹ˆë‹¤.",
        "faq_monitor_summary": "ìš”ì•½: ë³µìš© ì•½ë¬¼ì— ë”°ë¼ ê°„ê¸°ëŠ¥, ì „í•´ì§ˆ, í˜¸ë¥´ëª¬, ê³¨ë°€ë„ ê²€ì‚¬ í•­ëª©ì´ ë‹¬ë¼ì§‘ë‹ˆë‹¤.",
        "faq_slope_summary": "ìš”ì•½: ë†ë„ ë³€í™” ì†ë„ê°€ ë„ˆë¬´ ë¹ ë¥´ë©´ ê¸°ë¶„ ë³€ë™ ë“± ë¶€ì‘ìš© ìœ„í—˜ì´ ì»¤ì§‘ë‹ˆë‹¤.",
        "faq_high_e2_summary": "ìš”ì•½: ì§€ë‚˜ì¹˜ê²Œ ë†’ì€ ìˆ˜ì¹˜ëŠ” ì—¬ì„±í™” íš¨ìœ¨ë³´ë‹¤ ë¶€ì‘ìš© ìœ„í—˜ì„ ë” í‚¤ìš¸ ìˆ˜ ìˆìŠµë‹ˆë‹¤.",
        "faq_surgery_plan_summary": "ìš”ì•½: ì•ˆì „ ë„ë‹¬ì¼ì´ ìˆ˜ìˆ ì¼ë³´ë‹¤ ëŠ¦ìœ¼ë©´ ì¤‘ë‹¨ì¼ì„ ë” ì•ë‹¹ê²¨ì•¼ í•©ë‹ˆë‹¤.",
        "faq_units_summary": "ìš”ì•½: ë‹¨ìœ„ë§Œ ë‹¤ë¥¼ ë¿ ê°™ì€ ê°’ì´ë©° ì•±ì—ì„œ ìë™ ë³€í™˜ë©ë‹ˆë‹¤.",
        "faq_compare_summary": "ìš”ì•½: A/BëŠ” ë‘ ìŠ¤ì¼€ì¤„ì˜ ì°¨ì´ë¥¼ ë³´ëŠ” ë„êµ¬ì´ë©° PeakÂ·TroughÂ·ë³€ë™í­ì„ í•¨ê»˜ ë´ì•¼ í•©ë‹ˆë‹¤.",
        "faq_diff_summary": "ìš”ì•½: ê°œì¸ ëŒ€ì‚¬ ì°¨ì´ ë•Œë¬¸ì— ì‹¤ì œ ê²€ì‚¬ê°’ê³¼ ì˜ˆì¸¡ê°’ì€ ë‹¤ë¥¼ ìˆ˜ ìˆìœ¼ë©°, ë³´ì • íƒ­ìœ¼ë¡œ ì¤„ì¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤.",
        "faq_doctor_summary": "ìš”ì•½: ìƒë‹´ ì°¸ê³ ìë£Œë¡œëŠ” ìœ ìš©í•˜ì§€ë§Œ, ì˜í•™ì  íŒë‹¨ì„ ëŒ€ì‹ í•˜ì§€ëŠ” ì•ŠìŠµë‹ˆë‹¤.",
        "faq_data_privacy_summary": "ìš”ì•½: ì €ì¥ì€ ê¸°ë³¸ì ìœ¼ë¡œ ë¡œì»¬ ì¤‘ì‹¬ì´ë©°, ê³µìœ  ì „ ë¯¼ê°ì •ë³´ í™•ì¸ì´ í•„ìš”í•©ë‹ˆë‹¤.",
        "risk_summary_none": "ìœ„í—˜ ìš”ì•½: í˜„ì¬ ì„ íƒëœ ì£¼ìš” ìœ„í—˜ ìš”ì¸ì´ ì—†ìŠµë‹ˆë‹¤.",
        "risk_summary_some": "ìœ„í—˜ ìš”ì•½: {items}",
        "settings_caption": "ì „ì—­ ì„¤ì •ì…ë‹ˆë‹¤. ì „ì²´ ì•± ë™ì‘ì— ë°˜ì˜ë©ë‹ˆë‹¤."
    },
    "EN": {
        "tab_sim": "ğŸ“ˆ Simulation",
        "tab_safe": "ğŸš‘ Safety & Emergency",
        "tab_cal": "ğŸ§ª Calibration",
        "tab_surg": "ğŸ—“ï¸ Long-term Plan",
        "tab_rep": "ğŸ“‚ Import/Export",
        "tab_faq": "ğŸ“š FAQ & Ref",
        "sidebar_profile": "ğŸ§ 1. Body Profile",
        "sidebar_add": "ğŸ’Š 2. Add Medication",
        "sidebar_risk": "ğŸ›¡ï¸ 3. Risk Assessment",
        "sidebar_settings": "âš™ï¸ 4. Settings",
        "sidebar_patient": "ğŸ¥ Select Patient",
        "settings_lang_label": "ğŸŒ Language",
        "force_offline_label": "ğŸ› ï¸ Force Offline Mode",
        "force_offline_help": "Force behavior as if running in a local/offline environment.",
        "default_user": "user",
        "patient_name": "Patient Name",
        "patient_id_label": "Patient ID",
        "weight_label": "Weight (kg)",
        "height_label": "Height (cm)",
        "calculated_bmi": "ğŸ’¡ Calculated BMI: **{bmi:.1f}**",
        "age_label": "Age",
        "body_fat_label": "Body Fat (%)",
        "profile_details_toggle": "Detailed Inputs (Liver/Body Fat)",
        "ast_label": "AST (U/L)",
        "alt_label": "ALT (U/L)",
        "peak": "Peak",
        "trough": "Trough",
        "avg": "Average",
        "fluctuation": "Fluctuation",
        "max_slope": "Max Slope",
        "rmse_label": "RMSE (Error)",
        "splash_msg": "Initializing system. Please wait a moment.",
        "dashboard_title": "Dashboard",
        "landing_lang_label": "ğŸŒ Language",
        "landing_disclaimer_title": "âš ï¸ **Disclaimer Before Use**",
        "landing_disclaimer_intro": "**EstroFrame** is a **mathematical simulation tool** based on user-entered data.",
        "landing_disclaimer_item_1": "1. Results may differ from actual blood test values.",
        "landing_disclaimer_item_2": "2. The provided information does **not** replace medical diagnosis or prescription.",
        "landing_disclaimer_item_3": "3. Always consult your physician before changing dosage.",
        "landing_disclaimer_question": "Do you understand and agree to use this for reference purposes only?",
        "landing_agree_btn": "âœ… Agree & Start",
        "landing_welcome_title": "ğŸ‘‹ **Welcome to EstroFrame!**",
        "landing_steps_title": "### 3 steps to get started:",
        "landing_step_1": "1. Open the sidebar from the **top-left (>)**.",
        "landing_step_2": "2. In **[2. Add Medication]**, enter your current hormone regimen.",
        "landing_step_3": "3. If unsure, try the sidebar **'ğŸ£ Starter Set'** button.",
        "landing_demo_btn": "ğŸš€ Load Demo Data",
        "start_date_header": "ğŸ—“ï¸ Start Date",
        "start_date_label": "Simulation/Start Date",
        "start_date_help": "Day 0 is set based on this date. Used for .ics export.",
        "edit_scenario": "Select Scenario to Edit",
        "scenario_a": "Scenario A",
        "scenario_b": "Scenario B",
        "clone_a_to_b": "Clone A â¡ï¸ B",
        "starter_set_caption": "ğŸ£ **Starter Set (One-click Start)**",
        "starter_oral_cpa_btn": "ğŸ’Š Oral+CPA\n(2mg BID)",
        "starter_oral_cpa_help": "Most common oral regimen:\nâ€¢ Progynova 2mg (twice daily)\nâ€¢ Auto-enables Androcur (CPA) checklist",
        "starter_oral_cpa_toast": "âœ… Oral starter set applied! (CPA enabled)",
        "starter_injection_btn": "ğŸ’‰ Injection\n(10mg every 2 weeks)",
        "starter_injection_help": "Most common injection regimen:\nâ€¢ Depot injection 10mg (every 2 weeks)",
        "starter_injection_toast": "âœ… Injection starter set applied!",
        "select_route": "Select Route",
        "select_drug": "Select Drug",
        "dose_label": "Dose (mg)",
        "freq_mode": "Frequency",
        "freq_qd": "Once Daily (QD)",
        "freq_bid": "Twice Daily (BID)",
        "freq_tid": "Thrice Daily (TID)",
        "freq_custom": "Custom (Days)",
        "interval_days": "Interval (Days)",
        "cycle_interval": "Cycle Interval (Days)",
        "cycle_interval_help": "e.g., Enter 14 if injecting every 14 days",
        "cycling_mode": "Cycling Mode (Specific Days)",
        "cycling_mode_help": "e.g., Use for adding oral meds during the last 3 days of an injection cycle",
        "cycling_example": "ğŸ’¡ e.g., To take for the 'last 3 days' of a 14-day cycle -> Start: 11, Duration: 3",
        "cycle_start_day": "Start Day",
        "cycle_duration": "Duration",
        "delete_btn": "Delete",
        "add_schedule_btn": "â• Add to Schedule",
        "liver_block_toast": "Addition blocked due to liver risk!",
        "added_toast": "Added: {name}",
        "current_schedule_header": "Current Schedule ({label})",
        "protocol2_header": "ğŸ“‹ Protocol 2: Checklist",
        "protocol2_caption": "Select concomitant meds. (Excluded from simulation; used for safety analysis)",
        "check_spiro": "Spironolactone",
        "check_cpa": "Cyproterone Acetate (CPA)",
        "check_p4": "Progesterone",
        "check_gnrh": "GnRH Agonist (Puberty Blocker)",
        "interactors_header": "### ğŸ’Š Concomitant Medications & Supplements",
        "interactors_caption": "Are you taking any other medications or supplements?",
        "interactors_select": "Select concomitant medications (antibiotics, antidepressants, grapefruit, etc.)",
        "liver_critical_title": "ğŸš¨ **Block: Critical Liver Enzymes**",
        "liver_critical_msg": "Oral medication is blocked due to hepatotoxicity risk when AST or ALT >= 100 U/L.",
        "liver_critical_advice": "ğŸ’¡ **Recommended Alternative:** Transdermal (patches, gels) or injections bypass liver metabolism and are safer. Consult your doctor.",
        "smoker_label": "Current Smoker",
        "migraine_label": "Migraine w/ aura",
        "vte_hist_label": "Family/Personal History of VTE",
        "route_injection": "Injection",
        "route_oral": "Oral",
        "route_transdermal": "Transdermal (Patch/Gel)",
        "route_sublingual": "Sublingual",
        "route_anti_androgen": "Anti-Androgen",
        "route_progesterone": "Progesterone",
        "route_gnrh": "GnRH-Agonist",
        "safety_check_title": "ğŸ›¡ï¸ Clinical Safety Check",
        "search_patient": "Search Uploaded Patients",
        "load_data_btn": "Load Data",
        "update_db_btn": "Update Current Info to DB",
        "vte_score": "VTE Risk Score",
        "vte_level": "Risk Level",
        "model_rel": "Model Reliability",
        "unit_choice": "Unit",
        "gnrh_agonist": "GnRH-Agonist (Puberty Blocker)",
        "sim_days": "Duration (Days)",
        "compare_mode": "ğŸ”„ A/B Comparison",
        "risk_low": "Low",
        "risk_mod": "Moderate",
        "risk_high": "High",
        "risk_vhigh": "Very High",
        "rel_exc": "Excellent",
        "rel_good": "Good",
        "rel_poor": "Poor (Recalibrate)",
        "tanner_stage_msg": "âš ï¸ **[Adolescent Guideline]** Per WPATH SOC 8, clinical consultation based on Tanner Stage (Stage 2+) and consideration of puberty blockers are required.",
        "faq_tanner_q": "Q. How are Tanner Stages defined?",
        "faq_tanner_intro": "Tanner Stage is a standard index that classifies physical maturity from Stage 1 (pre-puberty) to Stage 5 (adult).",
        "tanner_stage": "Stage",
        "tanner_desc": "Physical Characteristics (Breast Focus)",
        "tanner_meaning": "Clinical Significance",
        "tanner_s1_desc": "ğŸŒ‘ **Stage 1**: Pre-pubertal. Only the papilla is elevated.",
        "tanner_s2_desc": "ğŸŒ¸ **Stage 2**: Breast bud forms; areola begins to widen.",
        "tanner_s3_desc": "ğŸˆ **Stage 3**: Further enlargement of breast and areola.",
        "tanner_s4_desc": "ğŸ’ **Stage 4**: Areola and papilla form a secondary mound.",
        "tanner_s5_desc": "ğŸ **Stage 5**: Mature stage. Areola recedes to general contour.",
        "tanner_s2_meaning": "**Onset of Puberty / Start of HRT Consideration**",
        "tanner_s5_meaning": "Adult development complete",
        "faq_monitor_q": "Q. What are the required monitoring tests for each medication?",
        "monitor_table_header_drug": "Medication",
        "monitor_table_header_exams": "Required/Recommended Exams",
        "monitor_table_header_desc": "Rationale & Notes",
        "monitor_row_common_drug": "Common",
        "monitor_row_common_exams": "E2, Total Testosterone",
        "monitor_row_common_desc": "Basic monitoring for all HRT patients",
        "monitor_row_gnrh_drug": "GnRH Agonist",
        "monitor_row_gnrh_exams": "LH, FSH, DXA (Bone Density)",
        "monitor_row_gnrh_desc": "Verify gonadal suppression & monitor bone loss",
        "monitor_row_spiro_drug": "Spironolactone",
        "monitor_row_spiro_exams": "Electrolytes (K+), Renal Function",
        "monitor_row_spiro_desc": "Monitor for hyperkalemia & renal function",
        "monitor_row_cpa_drug": "CPA (Cyproterone)",
        "monitor_row_cpa_exams": "Prolactin, LFT (Liver Function)",
        "monitor_row_cpa_desc": "Monitor for prolactin elevation & hepatotoxicity",
        "monitor_row_p4_drug": "Progesterone",
        "monitor_row_p4_exams": "Lipid Profile, BP, Weight",
        "monitor_row_p4_desc": "Metabolic markers & cardiovascular risk management",
        "sim_title": "Predicted Hormone Levels",
        "target_range": "Target Range (WPATH)",
        "intensive_24h_view": "ğŸ” 48h Intensive View (Steady State)",
        "intensive_24h_help": "View detailed circadian fluctuation during steady state.",
        "spike_warning": "Acute Spike Warning",
        "high_slope_risk": "High Slope Risk",
        "surgery_threshold": "Surgery Safety Threshold",
        "graph_title": "Predicted Serum Estradiol Levels",
        "xaxis_title": "Date",
        "stats_title": "Analysis Stats",
        "stats_steady_caption": "ğŸ’¡ Statistics are calculated based on the Steady State (90-180 days).",
        "monitoring_guide_title": "ğŸ©º Clinical Monitoring Guide",
        "monitoring_guide_info": "ğŸ’¡ **Guideline:** Reassess and titrate about every 3 months in the first year, then perform routine checks 1-2 times per year.",
        "fluctuation_help": "Lower fluctuation usually means less mood instability.",
        "max_slope_help": "Maximum concentration change in one day ({unit}/day)",
        "max_slope_risk_help": "Maximum concentration change in one day ({unit}/day). Risk of mood instability rises when exceeding 1000 pg/mL/day.",
        "rmse_help": "Average error between predicted curve and actual lab values. Lower is better.",
        "rmse_na_help": "No lab records available, so RMSE cannot be calculated.",
        "rmse_warning_msg": "âš ï¸ **High Prediction Error:** Large discrepancy between simulation and lab results. Use the [ğŸ§ª Calibration] tab to adjust.",
        "calib_notice": "ğŸ’¡ Graph is calibrated based on your lab results.",
        "monotherapy_success": "âœ… **T Suppression Zone (Monotherapy):** Estrogen levels are high enough (>200 pg/mL) to likely suppress testosterone without blockers.",
        "combo_info": "â„¹ï¸ **Combination Therapy:** Estrogen levels are low (<100 pg/mL), but **Anti-Androgens** are being used, so T suppression is likely maintained.",
        "low_estrogen_warning": "âš ï¸ **Low Estrogen & No Blocker:** Low estrogen and no anti-androgen may result in insufficient testosterone suppression.",
        "bone_risk": "ğŸ¦´ **Bone Health Risk:** Sex hormone (E2) levels are too low. Long-term deficiency risks osteoporosis.",
        "liver_risk": "**[Caution] Elevated Liver Enzymes:** Current AST({ast}) or ALT({alt}) exceed normal range. Consider switching to **Transdermal** or **Injections** to bypass liver metabolism.",
        "cessation_label": "Cessation",
        "resumption_label": "Resumption",
        "surgery_date_label": "Surgery Date",
        "actual_lab_results": "Actual Lab Results",
        "actual_measure": "Measured",
        "predicted_e2": "Predicted E2",
        "delta_caption": "ğŸ’¡ Delta (Î”) is relative to Scenario B.",
        "essential_exam": "â„¹ï¸ **Required Exams for {drug}:** {exams}",
        "emr_tab_title": "ğŸ“‚ Hospital Patient Database Management",
        "update_db_header": "â• Add/Update Current Patient to DB",
        "patient_updated_msg": "Patient '{label}' info updated.",
        "mount_db_header": "ğŸ¥ Mount Patient DB",
        "mount_db_caption": "Upload integrated DB (CSV) or individual patient files (JSON) to search in the sidebar.",
        "db_uploader_label": "Upload Patient DB or Record Bundle",
        "db_mount_merge_default_note": "Default behavior merges uploaded data into existing DB. The same files are not auto-reapplied.",
        "db_mount_replace_btn": "âš ï¸ Replace Entire DB with Upload",
        "db_mount_mode_applied": "DB mount applied: {mode} / {count} record(s)",
        "mount_success_msg": "Currently {count} patient(s) data mounted.",
        "download_db_btn": "ğŸ“¥ Download Full Patient DB (CSV)",
        "load_success_toast": "{name} loaded successfully",
        "db_select_default": "-- Select Patient --",
        "report_header": "ğŸ“‘ Report & Export",
        "pdf_section": "ğŸ“„ PDF Report",
        "pdf_caption": "Save current simulation and protocol as PDF.",
        "pdf_gen_btn": "Generate PDF",
        "pdf_download_btn": "ğŸ“¥ Download PDF",
        "pdf_warn_sim": "Please check the Simulation tab first.",
        "kaleido_install_hint": "This may be an environment issue. For local runs, install Kaleido with 'pip install kaleido'.",
        "ics_section": "ğŸ“… Google Calendar (.ics)",
        "ics_caption": "Add your schedule to your smartphone calendar.",
        "ics_download_btn": "ğŸ“… Download Calendar (.ics)",
        "ics_warn_empty": "Schedule is empty.",
        "json_section": "ğŸ’¾ Data Management (JSON)",
        "json_caption": "Backup or load settings and schedules.",
        "json_export_btn": "ğŸ’¾ Export Current Settings",
        "json_import_label": "ğŸ“‚ Import Data",
        "json_load_success": "Data loaded successfully.",
        "json_v2_error": "This file does not include full session state (JSON v2.0).",
        "pdf_generated_on": "Generated on",
        "pdf_profile_title": "1. User Profile",
        "pdf_protocol_title": "2. Medication Protocol",
        "pdf_graph_title": "3. Simulated Concentration",
        "pdf_protocol_header": "Drug Name / Type / Dose / Interval",
        "pdf_freq_format": "{dose}mg every {interval} days",
        "pdf_disclaimer": "DISCLAIMER: This report is a mathematical simulation and NOT medical advice. Blood levels may vary significantly. Consult a doctor before changing dosage.",
        "cal_header": "ğŸ§ª Route-specific Calibration",
        "cal_no_drugs": "Please add medications first.",
        "cal_lab_day": "Lab Day",
        "cal_lab_val": "Lab Result (pg/mL)",
        "cal_target_route": "Which route to calibrate?",
        "cal_injection_caption": "âš ï¸ **Caution:** For injections, mid-cycle lab results are important. Enter lab results from the middle of your dosing interval for accurate calibration.",
        "cal_oral_caption": "âš ï¸ **Caution:** Enter lab results taken right before dosing (trough). Post-dose blood draws can cause large prediction errors.",
        "cal_target_help": "Select your primary administration route. The error will be attributed to metabolic differences in this route.",
        "cal_add_record": "â• Add Lab Record",
        "cal_invalid_val": "Please enter a valid lab value.",
        "cal_success_msg": "âœ… {route} record added. Weighted average factor updated to {k:.2f}.",
        "cal_history_title": "#### ğŸ“‹ {route} Lab History",
        "cal_current_factors": "#### Currently Applied Calibration Factors",
        "cal_reset_btn": "Reset Calibration",
        "day_format": "Day {day}",
        "factor_label": "Factor",
        "surg_title": "ğŸ¥ Pre-op Hormone Cessation Plan",
        "surg_intro": "Stopping estrogen before surgery (especially with general anesthesia) may be recommended to reduce VTE risk.\nSimulate cessation timing and check safety levels here.",
        "surg_toggle": "Enable Surgery Mode (Apply to Simulation)",
        "surg_auto_recommend_label": "Auto-recommend stop/resume from surgery date",
        "surg_recommendation_msg": "Recommended schedule: stop {stop} / resume {resume}",
        "surg_type_label": "Select Surgery Type",
        "rec_cessation": "Recommended Cessation",
        "risk_extension": "Extended for Risk Group",
        "risk_label": "Risk Level",
        "first_hrt_date_label": "Date of First HRT",
        "first_hrt_date_help": "Enter the date you first started hormone therapy to assess surgery recommendations (WPATH).",
        "wpath_fail_msg": "ğŸš« **Below WPATH Recommendations:** Minimum {min} months of HRT is recommended. (Current: approx {curr} months)",
        "wpath_pass_msg": "âœ… **WPATH Recommendations Met:** HRT duration is {curr} months, meeting the recommended criteria.",
        "high_risk_warn": "âš ï¸ **Personalized Risk:** Your VTE risk score is {level}, so a longer cessation period than standard is recommended.",
        "vte_eval_title": "ğŸ©¸ Personalized VTE Risk Assessment",
        "risk_factors": "âš ï¸ Key Risk Factors: {factors}",
        "anesthesia_label": "Anesthesia Type",
        "anesthesia_gen": "General Anesthesia",
        "anesthesia_local": "Local Anesthesia",
        "anesthesia_help": "General anesthesia requires stricter level control due to higher VTE risk.",
        "date_stop_label": "1. Cessation Date",
        "date_surg_label": "2. Surgery Date",
        "date_resume_label": "3. Resumption Date",
        "resume_date_help": "Resumption is generally considered once normal ambulation is possible post-op.",
        "surg_graph_duration_label": "Surgery Graph Duration (Days)",
        "surg_graph_duration_help": "Display/analysis duration for the surgery tab. Default is 'resumption day + 30 days'.",
        "surg_analysis_title": "ğŸ“‹ Pre-op Analysis Results",
        "safe_msg": "âœ… **SAFE: Target Level Achievable**",
        "safe_zone": "âœ… Safe Zone (< 50 pg/mL)",
        "safe_date_msg": "â€¢ Estimated Safe Date: **{date}**",
        "safe_wait_msg": "â€¢ Levels drop below 50 pg/mL approx **{days:.1f} days** after stopping.",
        "unsafe_msg": "ğŸš« **WARNING: Levels not low enough by surgery date**",
        "unsafe_date_msg": "â€¢ Estimated Safe Date ({date}) is after the surgery date.",
        "unsafe_advice": "ğŸ’¡ Consider stopping earlier or consulting your doctor.",
        "sim_fail_msg": "âš ï¸ Safety level not reached within simulation range.",
        "resume_guide": "**ğŸ”„ Resumption Guideline:**\n- **Timing:** VTE risk is highest during immobility.\n- Resumption is usually considered when **Early Mobilization** (walking) is possible.\n- For {surg_name}, resumption is typically around {weeks} post-op, but ALWAYS consult your surgeon.",
        "surg_inactive_msg": "Toggle the switch above to start surgery simulation.",
        "bmi_high": "High BMI",
        "smoker": "Smoker",
        "vte_history": "History of VTE",
        "oral_estrogen": "Oral Estrogen",
        "ì„±í™•ì • ìˆ˜ìˆ  (Vaginoplasty/SRS)": "Vaginoplasty/SRS",
        "ê°€ìŠ´ ì„±í˜• (Breast Augmentation)": "Breast Augmentation",
        "ì•ˆë©´ ì—¬ì„±í™” ìˆ˜ìˆ  (FFS)": "Facial Feminization Surgery (FFS)",
        "ê³ í™˜ ì ˆì œìˆ  (Orchiectomy)": "Orchiectomy",
        "ê¸°íƒ€ ì „ì‹ ë§ˆì·¨ ìˆ˜ìˆ ": "Other General Anesthesia Surgery",
        "faq_title": "FAQ & References",
        "faq_cat_core": "Principles & Evidence",
        "faq_cat_changes": "Changes & Development",
        "faq_cat_safety": "Safety & Monitoring",
        "faq_cat_practical": "Interpretation & Use",
        "faq_intro": "**EstroFrame** is built upon evidence-based medicine. \nThe formulas and data sources used are as follows.",
        "faq_algo_q": "Q. How is the graph calculated? (Algorithm)",
        "faq_algo_a": "**1. Pharmacokinetics Model:**\nThis simulator is based on the **1-Compartment Open Model** and uses the **Bateman Function** to calculate absorption and elimination.\n\n$$ C(t) = \\frac{F \\cdot D \\cdot k_a}{V_d (k_a - k_e)} (e^{-k_e t} - e^{-k_a t}) $$\n\n- **$k_a$ (Absorption Constant):** Rate at which drug enters bloodstream (varies by route)\n- **$k_e$ (Elimination Constant):** Rate at which drug leaves the body (related to half-life)\n- **$V_d$ (Volume of Distribution):** Volume in which drug is distributed (adjusted by body weight)\n\n**2. Superposition Principle:**\nCalculates the steady state by summing up the residual concentrations of repeated doses over time.",
        "faq_ref_q": "Q. Where are the drug data and half-lives from? (References)",
        "faq_ref_a": "Key parameters such as half-life ($t_{1/2}$), bioavailability ($F$), and ester weight correction factors are referenced from:\n\n**1. Estrogen Pharmacokinetics (General):**\n> *Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(sup1), 3-63.* \n- Referenced metabolic pathways for Estradiol Valerate (EV) and oral formulations.\n\n**2. Injectable Estradiol (Depot):**\n> *Thurmann, P. A., et al. (2005). Pharmacokinetics of estradiol valerate... in healthy postmenopausal women. European Journal of Clinical Pharmacology.* \n- Referenced absorption patterns and time to peak for IM injections.\n\n**3. Transdermal (Gel/Patch):**\n> *Kuhl, H. (1990). Pharmacokinetics of oestrogens and progestogens. Maturitas.* \n- Referenced steady concentration characteristics of transdermal absorption.",
        "faq_guide_q": "Q. What are the standards for 'Target Levels' and 'Safety Warnings'?",
        "faq_guide_a": "Safety warnings and target blood levels follow international transgender health guidelines.\n\n**1. Target Levels:**\n> **WPATH SOC 8 (Standards of Care, Version 8)**\n- Recommended E2 for Transfeminine: **100 ~ 200 pg/mL**\n- Testosterone Suppression Target: **< 50 ng/dL**\n\n**2. Safety Warnings:**\n> **Endocrine Society Clinical Practice Guideline (2017)**\n- **VTE Risk:** Caution advised for oral estrogen in smokers over 35.\n- **Contraceptives (EE) Contraindicated:** Use of Ethinyl Estradiol is discouraged due to significantly higher VTE risk compared to bioidentical forms.\n\n**3. Anti-Androgen (CPA) Dosage:**\n> *Agence Nationale de SÃ©curitÃ© du MÃ©dicament (ANSM, France)* & *EMA (Europe)*\n- Low dose (10-12.5mg) recommended for Cyproterone (Androcur) due to meningioma risk with long-term high-dose use.",
        "faq_timeline_q": "Q. When do physical changes occur? (WPATH Timeline)",
        "faq_timeline_intro": "General timeline of physical changes according to WPATH SOC 8 guidelines.",
        "timeline_3_6m": "3~6 Months",
        "timeline_3_6m_desc": "â€¢ Breast budding starts\nâ€¢ Skin softening",
        "timeline_6_12m": "6~12 Months",
        "timeline_6_12m_desc": "â€¢ Decreased muscle mass\nâ€¢ Body fat redistribution (Female pattern)",
        "timeline_1_2y": "1~2 Years+",
        "timeline_1_2y_desc": "â€¢ Maximum breast growth\nâ€¢ Decreased body hair",
        "faq_diff_q": "Q. My lab results are different from the simulation.",
        "faq_diff_a": "**Of course.** The simulation is a mathematical model assuming an 'average human'.\nDifferences occur due to:\n\n- **Genetic Metabolic Differences:** Liver enzyme (CYP3A4, etc.) activity varies by person.\n- **Body Fat Percentage:** Estrogen can be stored in fat cells and released slowly.\n- **SHBG (Sex Hormone Binding Globulin):** Determines the ratio of Free E2 (Active) to Total E2.\n\nğŸ‘‰ Use the **[Calibration] tab** to input your lab results, and the simulator will adjust the graph to reflect your individual metabolism.",
        "faq_units_q": "Q. What's the difference between pg/mL and pmol/L?",
        "faq_units_a": "They represent the **same concentration** in different units.\n\n- pg/mL: mass-based unit\n- pmol/L: molar (molecule-count) unit\n\nEstroFrame converts automatically and uses **1 pg/mL â‰ˆ 3.6713 pmol/L** for estradiol (E2).",
        "faq_compare_q": "Q. How should I read A/B comparison mode?",
        "faq_compare_a": "A/B mode helps compare two schedules quickly.\n\n- Compare both curves over the same period and unit.\n- Î” on stat cards means the difference between scenarios.\n- Don't focus only on Peak; review **Trough, Fluctuation, and Max Slope** together.",
        "faq_surgery_plan_q": "Q. How do I interpret stop/surgery/resume dates in the surgery tab?",
        "faq_surgery_plan_a": "The surgery tab checks whether your level is in a safer range around surgery.\n\n- **Stop date:** when dosing is paused\n- **Surgery date:** reference date to check target level\n- **Resume date:** when restarting after clinical recovery (e.g., ambulation)\n\nIf the estimated safe date is later than surgery, consider moving stop date earlier with clinician guidance.",
        "faq_data_privacy_q": "Q. Where is my data stored? (privacy/security)",
        "faq_data_privacy_a": "By default, data is used within the current app/browser session.\n\n- Files are saved only when you explicitly export JSON/PDF/ICS.\n- Import/upload behavior follows your local workflow.\n- Before sharing, review exported files and remove unnecessary sensitive information.",
        "faq_doctor_q": "Q. Can I show these results to my doctor?",
        "faq_doctor_a": "**Yes, you can.** Print the PDF from the [Report] tab to use as a reference during consultation. \nHowever, please remember that this tool is not a medical device and cannot replace a doctor's prescription.",
        "faq_slope_q": "Q. What is the basis for the rapid change warning (100 pg/mL/d)?",
        "faq_slope_a": "This safety threshold is based on the physiological limit of estrogen fluctuation during ovulation in a natural menstrual cycle. Exceeding this rate may prevent neurotransmitters in the brain from adapting, increasing the likelihood of mood swings. (Estrogen Withdrawal Theory)",
        "faq_high_e2_q": "Q. Is higher estrogen always better? (Supraphysiological Levels)",
        "faq_high_e2_a": "**No. 'More is not always better.'**\n\nSupraphysiological levels can cause several issues:\n\n**1. Increased VTE Risk:**\n- Extremely high levels (like late pregnancy) can stimulate the liver to produce clotting factors, increasing the risk of blood clots, especially in smokers or older individuals.\n\n**2. Mood Swings:**\n- **'The Rollercoaster Effect'**: The higher the peak, the steeper the drop. Rapid withdrawal of estrogen can disrupt neurotransmitters, causing severe depression or headaches.\n\n**3. SHBG Elevation:**\n- The body produces more SHBG (Sex Hormone Binding Globulin) to bind excess estrogen. This can paradoxically lower **Free Estradiol** (the active form), reducing feminization efficiency.",
        "safe_center_title": "ğŸš‘ Safety Center",
        "emergency_self_check_title": "ğŸš¨ Emergency Symptom Self-check",
        "emergency_self_check_caption": "If you suspect VTE symptoms, stop dosing immediately and visit a hospital.",
        "dvt_title": "#### ğŸ¦µ Deep Vein Thrombosis (DVT)",
        "dvt_symptoms": "- **Leg swelling:** Noticeable swelling in one leg\n- **Pain:** Cramp-like calf pain or tenderness\n- **Warmth/Redness:** Affected area feels warm or appears red",
        "pe_title": "#### ğŸ« Pulmonary Embolism (PE) - Call emergency services now",
        "pe_symptoms": "- **Shortness of breath:** Sudden breathlessness\n- **Chest pain:** Sharp pain when breathing deeply\n- **Hemoptysis:** Coughing up blood\n- **Tachycardia:** Unexplained rapid heartbeat",
        "safe_center_tip": "ğŸ’¡ **Tip:** These are among the most serious adverse effects of hormone therapy. Extra caution is needed for **smokers** and **early post-op** patients.",
        "feminization_progress_title": "ğŸŒ¸ Feminization Progress",
        "feminization_current_status": "ğŸ“ **Current status:** {stage}",
        "missed_title": "ğŸš‘ Emergency: Missed a dose?",
        "missed_caption": "Guidance for what to do when you miss your dosing time.",
        "missed_add_drug_first": "Please add medication first.",
        "missed_select_drug": "Select missed medication",
        "missed_last_date": "Last dose date",
        "missed_last_time": "Last dose time",
        "missed_calc_btn": "Check Result (Calculate)",
        "missed_future_error": "You cannot enter a future time.",
        "missed_take_now_label": "âœ… **Take now**",
        "missed_skip_label": "â›” **Skip this dose**",
        "missed_next_due": "ğŸ“… Original next due time: {next}",
        "dev_credit": "Developed by **Jisong** (Medical Student) | Contact: jsbang01357@gmail.com",
        "risk_vte_smoker": "**[CRITICAL] Oral estrogen for smokers over 35** exponentially increases VTE risk. Switching to Transdermal (Patch/Gel) is strongly recommended.",
        "risk_vte_history": "**[DANGER] History of VTE** contraindicates oral formulations. Transdermal routes are safer.",
        "risk_migraine": "**[CAUTION] Migraine with aura** combined with oral estrogen may increase stroke risk.",
        "risk_dose_dumping": "**[WARNING] {label}Acute Concentration Spike (Dose Dumping) Detected:** Peak level exceeds {limit} pg/mL. This may cause severe mood swings, headaches, and nausea. Consider splitting doses (if sublingual) or adjusting dosage.",
        "reason_low_trough": "Trough level < 50 pg/mL",
        "risk_estrogen_super_high": "**[WARNING] Extremely High Estrogen:** Blood levels are far above the physiological range. Risk of blood clotting (VTE) may increase regardless of administration route.",
        "reason_high_slope": "Rapid concentration change",
        "risk_mood_swing": "**[CAUTION] Potential Mood Swings (PMS-like):** Due to {reasons}, you may experience depression, lethargy, or severe mood instability. Consider shortening intervals or changing formulation.",
        "ddi_inhibitor_title": "âš ï¸ Concentration Spike Warning ({med_name})",
        "ddi_inhibitor_msg": "{med_name} inhibits estrogen metabolism, potentially increasing blood levels. (Risk of Dose Dumping)",
        "ddi_inducer_title": "ğŸ“‰ Reduced Efficacy Warning ({med_name})",
        "ddi_inducer_msg": "{med_name} induces liver enzymes, metabolizing estrogen rapidly. Target levels may not be reached.",
        "ddi_spiro_title": "ğŸš¨ Hyperkalemia Risk ({med_name})",
        "ddi_spiro_msg": "Combining Spironolactone with {med_name} carries a risk of fatal hyperkalemia (arrhythmia, etc.). Consult a doctor immediately.",
        "risk_p4_side_effect": "âš ï¸ **[Caution] Progesterone Use:** Drowsiness, dizziness, breast pain, or edema may occur. Taking before bed is recommended to avoid daytime drowsiness.",
        "ts_1_label": "Tanner Stage 1 (Pre-pubertal)",
        "ts_1_desc": "Physical changes are just beginning.",
        "ts_2_label": "Tanner Stage 2 (Budding)",
        "ts_2_desc": "Breast buds begin to form.",
        "ts_3_label": "Tanner Stage 3 (Growth)",
        "ts_3_desc": "Fat redistribution and breast development accelerate.",
        "ts_4_label": "Tanner Stage 4 (Maturation)",
        "ts_4_desc": "Female body shape becomes distinct.",
        "ts_5_label": "Tanner Stage 5 (Adult)",
        "ts_5_desc": "Physical development has reached maturity.",
        "missed_overdue_msg": "Scheduled time has passed. Take immediately upon remembering, and reset the interval based on this new time.",
        "missed_skip_msg": "Only **{hours_left:.1f} hours** left until next dose (<50% of interval).\nSkipping this dose is recommended to avoid overdose. Resume at the next scheduled time.",
        "missed_take_msg": "There is still enough time before the next dose.\n**Take immediately upon remembering**, and proceed with the next dose as originally scheduled.",
        "fmt_months": "{months:.1f} months ({days} days)",
        "fmt_weeks": "{weeks:.1f} weeks ({days} days)",
        "fmt_days": "{days} days",
        "faq_algo_summary": "Summary: Concentration is computed from pharmacokinetic equations plus dose superposition.",
        "faq_ref_summary": "Summary: Core model inputs are based on published pharmacokinetic literature.",
        "faq_guide_summary": "Summary: Targets and warnings are aligned with major clinical guidelines.",
        "faq_timeline_summary": "Summary: Most changes appear gradually over months to years.",
        "faq_tanner_summary": "Summary: Tanner Stage objectively describes pubertal development level.",
        "faq_monitor_summary": "Summary: Monitoring priorities differ by medication class and risk profile.",
        "faq_slope_summary": "Summary: Faster concentration swings can increase mood-related side-effect risk.",
        "faq_high_e2_summary": "Summary: Excessively high levels often raise risks more than benefits.",
        "faq_surgery_plan_summary": "Summary: If safe date is later than surgery, move stop date earlier.",
        "faq_units_summary": "Summary: Same value, different units; conversion is automatic.",
        "faq_compare_summary": "Summary: Compare more than Peak; check trough and variability too.",
        "faq_diff_summary": "Summary: Individual biology causes mismatch; calibration reduces that gap.",
        "faq_doctor_summary": "Summary: Useful for discussion, but never a substitute for medical judgment.",
        "faq_data_privacy_summary": "Summary: Data handling is local-first; review files before sharing.",
        "risk_summary_none": "Risk summary: no major risk factors selected.",
        "risk_summary_some": "Risk summary: {items}",
        "settings_caption": "Global settings applied across the app."
    }
}
